Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,WASHINGTON, D.C. 20549

FORM 10-Q

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19342022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: file number: 001-39417

Evolv Technologies Holdings, Inc.

NEWHOLD INVESTMENT CORP.

(Exact nameName of registrantRegistrant as specifiedSpecified in its charter)Charter)

Delaware

Delaware

84-4473840

(State of Other Jurisdiction of Incorporation or other jurisdiction ofOrganization)

incorporation or organization)

(I.R.S. Employer

Identification Number)No.)

500 Totten Pond Road, 4th Floor, Waltham, MA

02451

(Address of Principal Executive Offices)

(Zip Code)

950 McCarty Street, Building A

Houston, TX

77029
(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: ((212) 653 0153781) 374-8100

Securities registered pursuant to Section 12(b) of the Act:

Not applicable

Name of each exchange

Title of each class

Trading Symbol(s)

on which registered

Common Stock, $0.0001 Par Value per Share
Warrants to purchase one share of Common Stock

EVLV

EVLVW

The Nasdaq Stock Market

The Nasdaq Stock Market

(Former name or former address, if changed since last report) 

Indicate by check mark whether the registrantregistrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrantRegistrant has submitted electronically every Interactive DateData File required to be submitted and pursuant to Rule 405 of Regulation S-T (§232.405232.0405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”,filer,” “accelerated filer,” “smaller reporting company”company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

Accelerated filer 

Non-accelerated filer

Smaller reporting company 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☐ 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per shareHCACThe NASDAQ Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50HCACWThe NASDAQ Stock Market LLC
Units, each consisting of one share of Class A Common Stock and three-quarters of one Redeemable WarrantHCACUThe NASDAQ Stock Market LLC

As of May 1, 2021,6, 2022, there were 17,250,000143,378,335 shares of the Company’s class A common stock, and 4,312,500 of its class B common stock issued and$0.0001 par value per share, outstanding.

NEWHOLD INVESTMENT CORP.

Table of Contents

TABLE OF CONTENTS

Page

PART I

Financial Information

Page

PART I – FINANCIAL INFORMATION

Item 1.

Financial Statements

Item 1.

Financial Statements:

Condensed Consolidated Balance Sheets (Unaudited)

F-1

Condensed Balance Sheets as of March 31, 2021 (unaudited) and December 31, 2021 (as restated)

1

Condensed Consolidated Statements of Operations for the three months ended March 31, 2021 (unaudited) and for the period from January 24, 2020 (date of inception) to March 31, 2020 (unaudited)Comprehensive Loss (Unaudited)

2

F-2

Condensed Consolidated Statements of Changes inConvertible Preferred Stock and Stockholders’ Equity for the three months ended March 31, 2021 (unaudited) and the period from January 24, 2020 (date of inception) to March 31, 2020 (unaudited)(Deficit) (Unaudited)

3

F-3

Condensed StatementConsolidated Statements of Cash Flows for the three months ended March 31, 2021 (unaudited) the period from January 24, 2020 (date of inception) to March 31, 2020 (unaudited)(Unaudited)

4

F-4

Notes to Condensed Consolidated Financial Statements (unaudited)

5

F-5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

15

1

Item 3.

Quantitative and Qualitative Disclosures About Market RiskRisks

21

17

Item 4.

Controls and Procedures

21

18

PART II – OTHER INFORMATION

Other Information

21

Item 1.

Legal Proceedings

23

21

Item 1A.

Risk Factors

23

21

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

23

21

Item 3.

Defaults Upon Senior Securities

23

21

Item 4.

Mine Safety Disclosures

23

21

Item 5.

Other Information

23

21

Item 6.

Exhibits

24

22

Signatures

25

23

i

FORWARD LOOKING STATEMENTS

PART 1 – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

NEWHOLD INVESTMENT CORP.

CONDENSED BALANCE SHEETS

  March 31,  December 31, 
  2021  2020 
  (unaudited)   
       
ASSETS      
Current assets:      
Cash $579,000  $1,328,000 
Prepaid expenses and other assets  193,000   184,000 
Total current assets  772,000   1,512,000 
Cash and investments held in trust account  172,598,000   172,579,000 
         
Total assets $173,370,000  $174,091,000 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current liabilities:        
Accounts payable and accrued liabilities $1,426,000  $677,000 
Accrued franchise taxes  50,000   83,000 
Total current liabilities  1,476,000   760,000 
Other liabilities:        
Warrant liability  24,165,000   21,519,000 
Deferred underwriting compensation  6,038,000   6,038,000 
Total liabilities  31,679,000   28,317,000 
         
Common stock subject to possible redemption; 13,669,161and 14,077,350 shares  (at value of approximately $10.00 per share)  136,691,000   140,774,000 
         
Commitments and contingencies        
         
Stockholders’ equity:        
Preferred stock, $0.0001 par value; 1,000,000 authorized shares; none   issued or outstanding  -   - 
Class A common stock, $0.0001 par value; 45,000,000 authorized shares;  3,580,839 and 3,172,650, respectively, at March 31, 2021 and December 31,  2020, issued and outstanding (excluding 13,669,161 and 14,077,350, respectively, subject to possible redemption at March 31, 2021 and December 31, 2020)  -   - 
Class B common stock, $0.0001 par value, 5,000,000 authorized shares 4,312,500 shares issued and outstanding  -   - 
Additional paid-in-capital  20,994,000   16,912,000 
Retained earnings (accumulated deficit)  (15,994,000)  (11,912,000)
Total stockholders’ equity  5,000,000   5,000,000 
         
Total liabilities and stockholders’ equity $173,370,000  $174,091,000 

See accompanying notesThis Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to condensed unaudited financialbe covered by the safe harbor provisions for forward-looking statements


NEWHOLD INVESTMENT CORP.

CONDENSED STATEMENTS OF OPERATIONS

  

Three Months
Ended

March 31, 2021

  For the Period From January 24, 2020 (date of inception) to March 31, 2020 
  (unaudited)  (unaudited) 
       
Revenues $-  $- 
General and administrative expenses  1,455,000   2,000 
Loss from operations  (1,455,000)  (2,000)
Other income (expense) –        
Income from Trust Account  19,000   - 
Change in fair value of warrant liability  (2,646,000)  - 
         
Income before provision for income tax  (4,082,000)  (2,000)
Provision for income tax  -   - 
Net loss $(4,082,000) $(2,000)
         
Two Class Method for Per Share Information:        
Weighted average Class A common shares outstanding - basic and diluted  17,250,000   - 
Net income per Class A common share – basic and Diluted $0.00  $0.00 
Weighted average Class B common shares outstanding – basic and diluted  4,312,500   4,312,500 
Net loss per Class B common share – basic and Diluted $(0.95) $(0.00)

See accompanying notes to condensed unaudited financial statements


NEWHOLD INVESTMENT CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

For the three months ended March 31, 2021 and for the period

from January 24, 2020 (date of inception) to March 31, 2020

(unaudited)

For the three months ended March 31, 2021:

  Common Stock  Additional  Retained Earnings  Total 
  Class A Shares  Amount  Class B Shares  Amount  Paid-in Capital  (Accumulated Deficit)  Stockholders’ Equity 
Balances, December 31, 2020  3,172,650  $-   4,312,500  $-  $ 16,912,000  $(11,912,000) $5,000,000 
Change in Class A common stock                            
subject to possible redemption  408,189   -   -   -   4,082,000   -   4,082,000 
Net loss  -   -   -   -   -   (4,082,000)  (4,082,000)
Balances, March 31, 2021 (unaudited)  3,580,839  $-   4,312,500  $-  $20,994,000  $(15,994,000) $5,000,000 

For the period from January 24, 2020 (date of inception) to March 31, 2020:

  Common Stock  Additional  Retained Earnings  Total 
  Class A Shares  Amount  Class B Shares  Amount  Paid-in Capital  (Accumulated Deficit)  Stockholders’ Equity 
Balances, January 24, 2020, (date of inception)  -  $-   -  $-  $-  $-  $- 
Sale of shares to Sponsor at $0.006 per share  -   -   4,312,500   -   25,000   -   25,000 
Net loss  -   -   -   -   -   (2,000)  (2,000)
Balances, March 31, 2020 (unaudited)  -  $-   4,312,500  $-  $25,000  $(2,000) $23,000 

See accompanying notes to condensed unaudited financial statements


NEWHOLD INVESTMENT CORP.

CONDENSED STATEMENT OF CASH FLOWS

(unaudited)

     For the period 
  For the
  from January 24, 
  three months ended  2020 (date of
inception) to
 
  March 31, 2021  March 31, 2020 
Cash flows from operating activities:      
Net loss $(4,082,000)  (2,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Income earned on the Trust Account  (19,000)  - 
Change in fair value of warrant liability  2,646,000   - 
Changes in operating assets and liabilities:        
Increase in prepaid expenses and other assets  (9,000)  - 
Increase in accounts payable and accrued liabilities  749,000   12,000 
Increase in accrued income and franchise taxes and rounding  (34,000)  - 
Net cash (used in) provided by operating activities  (749,000)  10,000 
Cash flows from investing activities: Cash deposited in Trust Account  -   - 
         
Cash flows from financing activities:        
Proceeds from sale of stock to Sponsor  -   25,000 
Proceeds from Note payable to Sponsor  -   7,000 
Payment of offering costs  -   (42,000)
Net cash provided by financing activities  -   (10,000)
         
Net increase in cash  (749,000)  - 
Cash at beginning of period  1,328,000   - 
Cash at end of period $579,000  $- 
         
Supplemental disclosure of non-cash financing activities:        
Offering costs included in accounts payable and accrued liabilities $-  $10,000 
Change in value of Class A common stock subject to redemption $4,082,000  $- 

See accompanying notes to condensed financial statements


NEWHOLD INVESTMENT CORP.

Notes to Condensed Financial Statements

(unaudited)

NOTE 1 – DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Organization and General:

NewHold Investment Corp. (the “Company”) was incorporated in Delaware on January 24, 2020 as NewHold Industrial Corp. and on February 14, 2020 changed its name to NewHold Investment Corp. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is an “emerging growth company,” as defined contained in Section 2(a)27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q may be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “forecasts,” “predicts,” “potential” or “continue” or the “Securities Act,” as modifiednegative of these terms or other similar expressions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to statements regarding our results of operations and financial position, business strategy, plans and prospects, existing and prospective products, research and development costs, timing and likelihood of success, and plans and objectives of management for future operations and results.

The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the Jumpstart Our Business Startups Actforward-looking statements, including, without limitation expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of 2012 (the “JOBS Act”).

Ascash, capital expenditures; the Company’s history of March 31, 2021,losses and lack of profitability; the Company’s reliance on third party contract manufacturing; the rate of innovation required to maintain competitiveness in the markets in which the Company had not commenced any operations. All activitycompetes; the competitiveness of the market in which the Company competes; the ability for the period from January 24, 2020 (date of inception)Company to March 31, 2021 relates toobtain, maintain, protect and enforce the Company’s formation andintellectual property rights; the initial public offering (“Public Offering”) described below, and subsequent to the Public Offering, searching for a potential business combination. The Company will not generate any operating revenues until after completion of its initial Business Combination, at the earliest. The Company expects to generate non-operating income in the form of interest income on the proceeds derived from the Public Offering.

All dollar amounts are rounded to the nearest thousand dollars.

Sponsor and Financing:

The Company’s sponsor is NewHold Industrial Technology Holdings LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Public Offering (as described in Note 3) was declared effective by the United States Securities and Exchange Commission (the “SEC”) on July 30, 2020. The Company intends to finance a Business Combination with proceeds from the $172,500,000 Public Offering (Note 4) and a $5,700,000 Private Placement (as defined in Note 4), net of expenses. Upon the closing of the Public Offering and the Private Placement, $172,500,000 was deposited in a trust account (the “Trust Account”).

The Trust Account:

The funds in the Trust Account can be invested only in U.S. government treasury bills with a maturity of one hundred and eighty five (185) days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940 which invest only in direct U.S. government obligations. Funds will remain in the Trust Account until the earlier of (i) the consummation of its initial Business Combination or (ii) the distribution of the Trust Account as described below. The remaining funds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisition targets and continuing general and administrative expenses.

The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay tax obligations and up to $250,000 per year for working capital purposes, if any, (less up to $100,000 of interest to pay dissolution expenses), none of the funds held in the Trust Account will be released until the earliest of: (a) the completion of the initial Business Combination, (b) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance or timing of the ability of holders of the public shares to seek redemption in connection with our initial business combination or the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within 24 months from the closing of the Public Offering, August 4, 2022, or (ii) with respect to any other provision relating to stockholders’ rights or pre-Business Combination activity, and (c) the redemption of the public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the Public Offering, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of creditors, if any, which could have priority over the claimsconcentration of the Company’s public stockholders.


Business Combination:

Therevenues on a single solution; the Company’s management has broad discretion with respectability to timely design, produce and launch its solutions, the specific applicationCompany’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the net proceeds ofCompany’s securities; geopolitical risk and changes in applicable laws or regulations; the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating a Business Combination with a Target Business. As used herein, “Target Business” is one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less deferred underwriting commissions and any taxes payable on interest earned) at the time of signing a definitive agreement in connection with the Company’s initial Business Combination. There is no assurancepossibility that the Company willmay be ableadversely affected by other economic, business, and/or competitive factors; operational risk; risk that the COVID-19 pandemic, including variants, vaccine roll-out efforts, and local, state, and federal responses to successfullyaddressing the pandemic may have an adverse effect on the Company’s business operations, as well as the Company’s financial condition and results of operations; litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources, and the important factors discussed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021. The forward-looking statements in this Quarterly Report on Form 10-Q are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a Business Combination.reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

You should read this Quarterly Report on Form 10-Q and the documents that we reference in this Quarterly Report on Form 10-Q and have filed as exhibits to this Quarterly Report on Form 10-Q with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this Quarterly Report on Form 10-Q, whether as a result of any new information, future events or otherwise.

GENERAL

We may announce material business and financial information to our investors using our investor relations website at https://ir.evolvtechnology.com/. We therefore encourage investors and others interested in Evolv to review the information that we make available on our website, in addition to following our filings with the SEC, webcasts, press releases and conference calls. Information contained on our website is not part of this Quarterly Report on Form 10-Q.

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)

March 31, 

December 31, 

2022

    

2021

Assets

  

 

  

Current assets:

  

 

  

Cash and cash equivalents

$

270,872

$

307,492

Restricted cash

400

400

Accounts receivable, net

 

8,589

 

6,477

Inventory

 

7,181

 

5,140

Current portion of contract assets

1,448

1,459

Current portion of commission asset

 

1,477

 

1,645

Prepaid expenses and other current assets

 

17,252

 

11,047

Total current assets

 

307,219

 

333,660

Restricted cash, noncurrent

275

275

Contract assets, noncurrent

 

3,321

 

3,418

Commission asset, noncurrent

4,239

3,719

Property and equipment, net

 

25,282

 

21,592

Operating lease right-of-use assets

2,287

Other assets

1,275

401

Total assets

$

343,898

$

363,065

Liabilities and Stockholders’ Equity

 

  

 

  

Current liabilities:

 

  

 

  

Accounts payable

$

4,645

$

6,363

Accrued expenses and other current liabilities

 

7,118

 

9,183

Current portion of deferred revenue

 

7,433

 

6,690

Current portion of deferred rent

 

 

135

Current portion of long-term debt

 

3,000

 

2,000

Current portion of operating lease liabilities

1,089

Total current liabilities

 

23,285

 

24,371

Deferred revenue, noncurrent

 

4,517

 

2,475

Deferred rent, noncurrent

333

Long-term debt, noncurrent

 

6,950

 

7,945

Operating lease liabilities, noncurrent

1,634

Contingent earn-out liability

 

18,128

 

20,809

Contingently issuable common stock liability

3,792

5,264

Public warrant liability

5,444

11,030

Total liabilities

 

63,750

 

72,227

Commitments and contingencies (Note 20)

 

  

 

  

Stockholders’ equity:

 

  

 

  

Preferred stock, $0.0001 par value; 100,000,000 shares authorized at March 31, 2022 and December 31, 2021; 0 shares issued and outstanding at March 31, 2022 and December 31, 2021

 

 

Common stock, $0.0001 par value; 1,100,000,000 shares authorized at March 31, 2022 and December 31, 2021; 143,322,036 and 142,745,021 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively

 

14

 

14

Additional paid-in capital

 

399,424

 

395,563

Accumulated deficit

 

(119,290)

 

(104,739)

Stockholders’ equity

 

280,148

 

290,838

Total liabilities and stockholders’ equity

$

343,898

$

363,065

The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approvalaccompanying notes are an integral part of these condensed consolidated financial statements.

F-1

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share amounts)

(Unaudited)

Three Months Ended March 31, 

2022

2021

Revenue:

Product revenue

$

5,194

$

2,502

Subscription revenue

3,020

1,300

Service revenue

501

197

Total revenue

8,715

3,999

Cost of revenue:

Cost of product revenue

5,576

2,229

Cost of subscription revenue

1,065

595

Cost of service revenue

448

127

Total cost of revenue

7,089

2,951

Gross profit

1,626

1,048

Operating expenses:

Research and development

4,286

3,612

Sales and marketing

12,053

3,684

General and administrative

11,093

2,899

Loss from impairment of property and equipment

96

Total operating expenses

27,528

10,195

Loss from operations

(25,902)

 

(9,147)

Other income (expense), net:

Interest expense

(142)

 

(2,447)

Interest income

209

Change in fair value of derivative liability

(1,425)

Change in fair value of contingent earn-out liability

4,226

Change in fair value of contingently issuable common stock liability

1,472

Change in fair value of public warrant liability

5,586

Change in fair value of common stock warrant liability

(736)

Total other income (expense), net

11,351

 

(4,608)

Net loss and comprehensive loss – basic and diluted

$

(14,551)

$

(13,755)

Net loss per share – basic and diluted

$

(0.10)

$

(1.32)

Weighted average common shares outstanding – basic and diluted

142,878,406

10,443,323

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-2

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND

STOCKHOLDERS' EQUITY (DEFICIT)

(In thousands, except share amounts)

(Unaudited)

Convertible

Additional

Total

Preferred Stock

Common Stock

Paid-in

Accumulated

Stockholders’

    

Shares

    

Amount

    

    

Shares

    

Amount

    

Capital

    

Deficit

    

Equity (Deficit)

Balance at December 31, 2021

$

142,745,021

$

14

$

395,563

$

(104,739)

$

290,838

Issuance of common stock upon net exercise of stock options

496,971

216

216

Issuance of common stock upon vesting of restricted stock units

80,044

Stock-based compensation expense

3,645

3,645

Net loss

 

 

 

 

 

 

(14,551)

 

(14,551)

Balance at March 31, 2022

 

$

 

143,322,036

$

14

$

399,424

$

(119,290)

$

280,148

Balance at December 31, 2020

 

77,340,057

 

75,877

 

9,846,830

 

1

 

9,194

$

(93,881)

$

(84,686)

Issuance of warrants to purchase common stock

 

 

 

 

 

1

 

 

1

Issuance of common stock upon exercise of stock options

 

 

 

1,563,281

 

 

455

 

���

 

455

Stock-based compensation expense

 

 

 

 

 

1,082

 

 

1,082

Net loss

 

 

 

 

 

 

(13,755)

 

(13,755)

Balance at March 31, 2021

 

77,340,057

$

75,877

 

11,410,111

$

1

$

10,732

$

(107,636)

$

(96,903)

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-3

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

Three Months Ended March 31, 

2022

    

2021

Cash flows from operating activities:

  

 

  

Net loss

$

(14,551)

$

(13,755)

Adjustments to reconcile net loss to net cash used in operating activities:

 

  

 

  

Depreciation and amortization expense

 

948

 

452

Write down of inventory

324

Adjustment to property and equipment for sales type leases

(321)

Loss from impairment of property and equipment

96

Stock-based compensation

 

5,190

 

1,082

Noncash interest expense

 

5

 

2,344

Noncash lease expense

197

Recovery of allowance for doubtful accounts

(63)

Change in fair value of derivative liability

1,425

Change in fair value of common stock warrant liability

736

Change in fair value of earn-out liability

(4,226)

Change in fair value of contingently issuable common stock

(1,472)

Change in fair value of public warrant liability

(5,586)

Changes in operating assets and liabilities

Accounts receivable

 

(2,112)

 

(874)

Inventory

 

(6,985)

 

(433)

Commission assets

 

(351)

 

(391)

Contract assets

108

(119)

Prepaid expenses and other current assets

 

(5,280)

 

(4,104)

Accounts payable

 

(1,867)

 

1,194

Deferred revenue

 

2,778

 

(621)

Deferred rent

 

(468)

 

(11)

Accrued expenses and other current liabilities

(2,065)

1,100

Operating lease liabilities

 

(229)

 

Net cash used in operating activities

 

(35,867)

 

(12,038)

Cash flows from investing activities:

 

  

 

  

Development of internal-use software

(646)

Purchases of property and equipment

 

(323)

 

(2,522)

Net cash used in investing activities

 

(969)

 

(2,522)

Cash flows from financing activities:

 

  

 

  

Proceeds from exercise of stock options

 

216

 

455

Repayment of financing obligations

 

 

(359)

Proceeds from long-term debt, net of issuance costs

31,882

Net cash provided by financing activities

 

216

 

31,978

Net increase (decrease) in cash, cash equivalents and restricted cash

 

(36,620)

 

17,418

Cash, cash equivalents and restricted cash

 

  

 

  

Cash, cash equivalents and restricted cash at beginning of period

 

308,167

 

4,704

Cash, cash equivalents and restricted cash at end of period

$

271,547

$

22,122

Supplemental disclosure of cash flow information

Cash paid for interest

$

133

$

103

Supplemental disclosure of non-cash activities

 

  

 

  

Transfer of inventory to property and equipment

$

4,620

$

Capital expenditures incurred but not yet paid

1,693

Issuance of equity classified warrants

1

Reconciliation of cash, cash equivalents and restricted cash:

Cash and cash equivalents

$

270,872

$

22,122

Restricted cash

400

Restricted cash, noncurrent

275

Total cash, cash equivalents and restricted cash shown in the statements of cash flows

$

271,547

$

22,122

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-4

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Nature of the Business Combination atand Basis of Presentation

Evolv Technologies Holdings, Inc. (the “Company”), a meeting calledDelaware corporation, is a global leader in AI-based weapons detection for such purposesecurity screening. The Company’s mission is to make the world a safer and more enjoyable place to work, learn, and play. The Company is democratizing security by making it seamless for gathering spaces to address the chronic epidemic of escalating gun violence, mass shootings and terrorist attacks in connection witha cost-effective manner while improving the visitor experience. The Company is headquartered in Waltham, Massachusetts.

As used in this Quarterly Report on Form 10-Q, unless otherwise indicated or the context otherwise requires, references to “we,” “us,” “our,” the “Company” and “Evolv” refer to the consolidated operations of Evolv Technologies Holdings, Inc. and its wholly owned subsidiaries, which stockholders may seekinclude Evolv Technologies, Inc., Evolv Technologies UK Ltd. and Give Evolv LLC. References to redeem their shares, regardless of whether they vote for or against“NHIC” refer to the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business dayscompany prior to the consummation of the initial Business Combination, including interest but less taxes payableMerger (as defined in Note 3) and amounts released for working capital, or (ii) provide stockholders with the opportunityreferences to have their shares redeemed by the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal“Legacy Evolv” refer to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business daysEvolv Technologies, Inc. dba Evolv Technology, Inc. prior to the consummation of the initial Business Combination, including interest but less taxes payable and amounts released to the Company for working capital. Merger.

Basis of presentation

The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by the rules of the Nasdaq Capital Market. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of Class A and Class B common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its public shares and the related Business Combination, and instead may search for an alternate Business Combination.

If the Company holds a stockholder vote or there is a tender offer for shares in connection with a Business Combination, a public stockholder willcondensed consolidated financial statements have the right to redeem its shares for an amount in cash equal to its pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest but less taxes payable and amounts released to the Company for working capital. As a result, such shares of Class A common stock will be recorded at redemption amount and classified as temporary equity upon the completion of the Public Offering,been prepared in accordance with FASB ASC 480, “Distinguishing Liabilities from Equity.” In August 2020, the Company deposited an aggregate of $172,500,000 from the proceeds of the Public Offering, including the underwriters’ exercise of their overallotment option and the sale of $5,700,000 for the Private Placement Warrants, net of expenses.

The Company will have 24 months (until August 4, 2022) from the closing date of the Public Offering to complete its initial Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares of Class A common stock for a per share pro rata portion of the Trust Account, including interest, but less taxes payable and amounts released for working capital (less up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining stockholders, as part of its plan of dissolution and liquidation. The initial stockholders have entered into letter agreements with us, pursuant to which they have waived their rights to participate in any redemption with respect to their initial shares; however, if the initial stockholders or any of the Company’s officers, directors or affiliates acquire shares of Class A common stock in or after the Public Offering, they will be entitled to a pro rata share of the Trust Account upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within 24 months from the closing of the Public Offering.

In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the price per Unit in the Public Offering.

NOTE 2 – MERGER AGREEMENT

On March 5, 2021, NewHold Investment Corp., (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, NHIC Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), and Evolv Technologies, Inc. dba Evolv Technology, Inc., a Delaware corporation (“Evolv”). Pursuant to the terms of the Merger Agreement, a business combination between NewHold and Evolv will be effected through the merger of Merger Sub with and into Evolv, with Evolv surviving the merger as a wholly owned subsidiary of the Company (the “Merger”). The Board of Directors of the Company (the “Board”) has unanimously (i) approved and declared advisable the Merger Agreement, the Merger and the other transactions contemplated thereby and (ii) resolved to recommend approval of the Merger Agreement and related matters by the stockholders of The Company.


Evolv is engaged in the business of providing artificial intelligence touchless security screening. Evolv is based in Waltham, Massachusetts.

More complete information about the Merger Agreement and related Support Agreement, Amended and Restated Insider Letter Agreement, form of Subscription Agreement and Stockholder Agreement are filed with the Current Report on Form 8-K filed on March 8, 2021.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation:

The accompanying unaudited condensed interim financial statements of the Company are presented in U.S. dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) pursuantand include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the rulesauthoritative GAAP as found in the Accounting Standards Codification (“ASC”) and regulationsAccounting Standards Update (“ASU”) of the SECFinancial Accounting Standards Board (“FASB”).

All share and reflect all adjustments, consisting onlyper share amounts contained herein for periods prior to the Merger have been retroactively adjusted to give effect to the Exchange Ratio (as defined in Note 3), unless otherwise indicated.

Unaudited Interim Financial Information

The accompanying unaudited condensed consolidated financial statements as of normal recurring adjustments, which are,March 31, 2022, and for the three months ended March 31, 2022 and 2021 have been prepared on the same basis as the audited annual consolidated financial statements as of December 31, 2021 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for athe fair presentationstatement of the Company’s financial position as of March 31, 2021,2022 and the results of its operations for the three months ended March 31, 2022 and 2021 and cash flows for the periods presented. Certain informationthree months ended March 31, 2022 and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. Interim2021. The results for the three months ended March 31, 2022 are not necessarily indicative of results to be expected for a full year.the year ending December 31, 2022, any other interim periods, or any future year or period.

2. Summary of Significant Accounting Policies

Significant Accounting Policies

The accompanyingsignificant accounting policies and estimates used in preparation of the unaudited condensed interimconsolidated financial statements should be readare described in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2021, and the notes thereto, which are included in our Annual Report on Form 10-K. There have been no material changes to the Company’s significant accounting policies during the three months ended March 31, 2022 outside of the items as described below.

F-5

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Leases as a Lessee

Prior to January 1, 2022, the Company accounted for leases in accordance with ASC 840, Leases. At lease inception, the Company determined if an arrangement was an operating or capital lease. For operating leases, the Company recognized rent expense, inclusive of rent escalation, on a straight-line basis over the lease term.

Effective on January 1, 2022, the Company accounts for leases in accordance with ASC 842, Leases. At contract inception, the Company determines if an arrangement is or contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If determined to be or contain a lease, the lease is assessed for classification as either an operating or finance lease at the lease commencement date, defined as the date on which the leased asset is made available for use by the Company (when the Company is the lessee). Where the Company is the lessee, for each lease with a term greater than twelve months, the Company records a right-of-use asset and lease liability.

A right-of-use asset represents the economic benefit conveyed to the Company by the right to use the underlying asset over the lease term. A lease liability represents the obligation to make lease payments arising from the use of the asset over the lease term. Lease liabilities are measured at lease commencement and calculated as the present value of the future lease payments in the contract using the rate implicit in the contract, when available. If an implicit rate is not readily determinable, the Company uses an incremental borrowing rate measured as the rate at which the Company could borrow, on a fully collateralized basis, a commensurate loan in the same currency over a period consistent with the lease term at the commencement date. Right-of-use assets are measured as the amount of the initial lease liability plus initial direct costs and prepaid lease payments, less lease incentives granted by the lessor. The lease term is measured as the noncancelable period in the contract, adjusted for any options to extend or terminate when it is reasonably certain the Company will extend the lease term via such options based on an assessment of economic factors present as of the lease commencement date. The Company elected the practical expedient to not recognize leases with a lease term of twelve months or less.

Components of a lease are split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) are allocated, based on the respective relative fair values, to the lease components and non-lease components. The Company has elected the practical expedient to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only.

The Company’s operating leases are presented in the condensed consolidated balance sheet as operating lease right-of-use assets, classified as noncurrent assets, and operating lease liabilities, classified as current and noncurrent liabilities. Operating lease expense is recognized on a straight-line basis over the lease term. Variable costs associated with a lease, such as maintenance and utilities, are not included in the measurement of the lease liabilities and right-of-use assets but rather are expensed when the events determining the amount of variable consideration to be paid have occurred.

Subscription Revenue - Leases as Lessor

In addition to selling our products directly to customers, we also derive revenue from leasing our equipment, which we classify as subscription revenue. Lease terms are typically four years, do not include options to extend, terminate or to purchase the underlying asset, and customers generally pay either a quarterly or annual fixed payment for the lease and maintenance elements over the contractual lease term. Equipment leases are generally classified as operating leases as they do not meet any of the sales-type lease criteria per ASC 842 and recognized ratably over the duration of the lease. There are no variable lease payments as a part of these arrangements.

The accounting provisions we use to classify transactions as sales-type are: (i) whether the lease transfers ownership of the equipment by the end of the lease term, (ii) whether the lease grants the customer an option to purchase the equipment and the customer is reasonably certain to do so, (iii) whether the lease term is for the major part of the economic life of the underlying equipment, (iv) whether the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (v) whether the equipment is specific to the customer and of such a specialized nature that it is expected to have no alternative use to the Company at the end of

F-6

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

the lease term. Leasing arrangements meeting any of these conditions are accounted for as sales-type leases and revenue attributable to the lease component is recognized in a manner consistent with the equipment sales and the related equipment is derecognized with the associated expense presented as a cost of revenue. Leasing arrangements that do not meet the criteria for classification as a sales-type lease will be accounted for as a direct-financing lease if the following two conditions are met: (i) the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments and any other third party unrelated to the Company, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (ii) it is probable that the Company will collect the lease payments and amounts necessary to satisfy a residual value guarantee. Leasing arrangements that do not meet any of the sales-type lease classification criteria are accounted for as operating leases and revenue is recognized straight-line over the term of the lease.

The Company considers the economic life of most of our products to be seven years. The Company believes seven years is representative of the period during which the equipment is expected to be economically usable by one or more users, with normal service, for the purpose for which it is intended. The unguaranteed residual value is estimated to be the value at the end of the lease term based on the anticipated fair market value of the units. The Company mitigates residual value risk of our leased equipment by performing regular management and maintenance, as necessary.

Generally, lease arrangements include both lease and non-lease components. The lease component relates to the customer’s right-to-use the equipment over the lease term. The non-lease components relate to (1) distinct services, such as SaaS and maintenance, (2) any add-on accessories, and (3) installation and training. Installation and training are included in service revenue as described below, and add-on accessories are included in product revenue. Because the equipment, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern, the Company elected the practical expedientto aggregate non-lease components with the associated lease component and account for the combined component as an operating lease for all underlying asset classes.In the evaluation of whether the lease component (equipment) or the non-lease components associated with the lease component (SaaS and maintenance) is the predominant  component, the Company determined that the lease component is predominant as customers would clearly be expected to ascribe more value to the use of the security equipment than that of the SaaS and maintenance services.Therefore, the Company will account for the combined lease component under ASC 842. The equipment lease and SaaS/maintenance performance obligations are classified as a single category of subscription revenue in the condensed consolidated statements of operations and comprehensive loss. The installation and training services represent distinct services provided to customers. These activities are considered separate performance obligations to the customer and therefore are considered non-lease components. As installation and training services are performed prior to lease commencement, the timing and pattern of transfer for these services differ from that of the lease component (i.e., security hardware) and are not eligible to be combined.

We exclude from variable payments all lessor costs that are explicitly required to be paid directly by a lessee on behalf of the lessor to a third party. Revenue related to leases entered into with related parties were $0.1 million during the three months ended March 31, 2022.

Installation and training are generally billed to the lessee as part of the lease contract billing, according to various contractual terms. The installation and training costs incurred by the Company are accounted for as a fulfillment cost and are included in the cost of services revenue in the condensed consolidated statements of operations and comprehensive loss.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”), as subsequently amended (collectively “ASC 842”). The guidance amends the existing accounting standards for lease accounting, including requirements for lessees to recognize assets and liabilities related to long-term leases on the balance sheet and expanding disclosure requirements regarding leasing arrangements. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. Lessors are required to classify leases as a sales-type, direct financing, or operating lease. A lease is a sales-type lease if it effectively transfers control of the underlying asset to the lessee as indicated by any one of five criteria being met. All leases that are not sales-type or direct financing leases will be classified as operating leases. In July 2018, the FASB issued additional guidance, which offers a transition option to entities adopting ASC 842 in which entities can elect to

F-7

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

apply the new guidance using a modified retrospective approach at the beginning of the year in which the new lease standard is adopted. The Company utilized this transition option whereby financial information for prior periods presented before the ASC 842 effective date will not be updated. In November 2019, the FASB issued ASU 2019-10 deferring the effective date for private entities (also applicable for public companies that qualify as emerging growth companies) for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021. In June 2020, the FASB issued ASU 2020-05 which further defers the effective date for private entities for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022.

The Company adopted this guidance effective January 1, 2022. ASC 842 provides several optional practical expedients in transition. The Company applied the ‘package of practical expedients’ which allow the Company to not reassess whether existing or expired arrangements contain a lease, the lease classification of existing or expired leases, or whether previous initial direct costs would qualify for capitalization under ASC 842.

The adoption of ASC 842 resulted in the recognition of operating lease liabilities of $3.0 million and operating right-of-use assets of $2.5 million, along with the write-off of certain deferred rent balances of $0.5 million within the Company’s condensed consolidated balance sheets as of January 1, 2022. The adoption did not have a significant impact on the Company’s condensed consolidated statements of operations and comprehensive loss and condensed consolidated statements of cash flows.

In December 2019, the FASB issued ASU 2019 12, Income Taxes (ASC 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various areas related to accounting for income taxes. ASU 2019 12 removes certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. For public entities the guidance is effective for annual reporting periods beginning after December 15, 2020 and for interim periods within those fiscal years. For non-public entities, the guidance is effective for annual reporting periods beginning after December 15, 2021 and for interim periods within years beginning after December 15, 2022, with early adoption permitted. The Company adopted this guidance effective January 1, 2022 and the adoption of this guidance did not have a material impact on its condensed consolidated financial statements and notes thereto includedrelated disclosures.

In August 2020, the FASB issued ASU 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity,” which simplifies and clarifies certain calculation and presentation matters related to convertible and equity and debt instruments. Specifically, ASU 2020-06 removes requirements to separately account for conversion features as a derivative under ASC Topic 815 and removing the requirement to account for beneficial conversion features on such instruments. ASU 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the Company’s final prospectus dated July 28, 2020,calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this guidance effective January 1, 2022 and the adoption of this guidance did not have a material impact on its condensed consolidated financial statements and related disclosures.

Recently Issued Accounting Pronouncements

The Company qualifies as wellan “emerging growth company” as defined in the Company’s Annual Report, Amendment #1 on Form 10-K/A filed withJumpstart Our Business Startups Act of 2012 and has elected not to “opt out” to the SEC on May 14, 2021.

Emerging Growth Company

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being requiredextended transition related to complycomplying with new or revised financial accounting standards, until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accountinga standard is issued or revised and it has different application dates for public or privateand nonpublic companies, the Company as an emerging growth company, canwill adopt the new or revised standard at the time privatenonpublic companies adopt the new or revised standard.standard and will do so until such time that the Company either (1) irrevocably elects to “opt out” of such extended transition period or (2) no longer qualifies as an emerging growth company. The Company may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for nonpublic companies.

F-8

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The new standard adjusts the accounting for assets held at amortized cost basis, including marketable securities accounted for as available for sale, and trade receivables. The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities except smaller reporting companies, the guidance is effective for annual reporting periods beginning after December 15, 2019 and for interim periods within those fiscal years. In November 2019, the FASB issued ASU No. 2019-10, which deferred the effective date for non-public entities to annual reporting periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is allowed. The Company expects to adopt this guidance effective January 1, 2023, and it is currently evaluating the impact on its condensed consolidated financial statements and related disclosures.

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The amendments in ASU 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company expects to adopt this guidance effective January 1, 2023, and it is currently evaluating the impact on its condensed consolidated financial statements and related disclosures.

Out-of-Period Adjustment

During the three months ended March 31, 2022, the Company recorded an immaterial out-of-period adjustment that resulted in a $1.0 million increase of stock-based compensation expense within sales and marketing expense in the condensed statements of operations and comprehensive loss, a $1.0 million increase to change in fair value of contingent earn-out liability in the condensed statements of operations and comprehensive loss, a $0.5 million decrease to additional paid-in capital in the condensed balance sheets, and a $0.5 million increase to contingent earn-out liability in the condensed balance sheets. The out-of-period adjustment related to an error in the Company’s accounting for the contingent earn-out liability for the third and fourth quarters of fiscal year 2021. The Company has determined the adjustment is not material to the current period or any previously issued financial statements.

3. Merger with NHIC and Related Transactions

On July 16, 2021, we consummated the business combination (the “Merger”), contemplated by the Agreement and Plan of Merger, dated March 5, 2021, with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the Merger as a wholly owned subsidiary of NHIC. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC pursuant to Rule 12g-3(a) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The transaction was accounted for as a “reverse recapitalization” in accordance with GAAP. Under this method of accounting, NHIC was treated as the “acquired” company for financial reporting purposes. This may make comparisondetermination was primarily because subsequent to the Merger, Legacy Evolv’s shareholders have a majority of the voting power of the combined company, Legacy Evolv comprises all of the ongoing operations of the combined entity, Legacy Evolv comprises a majority of the governing body of the combined company, and Legacy Evolv’s senior management comprises all of the senior management of the combined company. Accordingly, for accounting purposes, this

F-9

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

transaction was treated as the equivalent of Legacy Evolv issuing shares for the net assets of NHIC, accompanied by a recapitalization. The shares and net loss per common share, prior to the Merger, have been retroactively restated as shares reflecting the Exchange Ratio established in the Merger. The net assets of NHIC were recorded at historical costs, with 0 goodwill or other intangible assets recorded. Operations prior to the Reverse Recapitalization are those of Legacy Evolv.

Evolv had previously indicated that it would list units (consisting of 1 share of common stock and one-half of one warrant) on Nasdaq under the ticker symbol EVLVU, in continuation of the listing of the units NHIC sold in its initial public offering on August 4, 2020 under the ticker symbol NHICU. In September 2021, our transfer agent separated the units into the component shares and warrants at the closing of the Merger, and as a result the Evolv units were not made eligible to settle through the facilities of The Depositary Trust Company. Accordingly, all trades in the units from July 19, 2021 (the first trading day after the completion of the Merger) until August 24, 2021 were settled between brokers in the shares and warrants underlying the units. Trading in ticker symbol EVLVU was halted on August 24, 2021, and no trades in the units were permitted or occurred since that date. The units were delisted from Nasdaq effective September 10, 2021.

Upon closing of the Merger each share of NHIC Class B common stock issued and outstanding immediately prior to the effective time of the Merger, which totaled 10,391,513 shares held by the NHIC Initial Shareholders (“Initial Shareholders”), was automatically converted into one validly-issued share of our common stock.

In addition, pursuant to the Merger Agreement, certain Legacy Evolv Shareholders became entitled to receive up to 15,000,000 shares of common stock as earn-out shares.

Upon closing of the Merger:

all of 24,359,107 shares of Legacy Evolv’s Series A-1 convertible preferred stock were converted into an equivalent number of shares of Legacy Evolv common stock on a 1-to-one basis;
all of 3,484,240 shares of Legacy Evolv’s Series A convertible preferred stock were converted into an equivalent number of shares of Legacy Evolv common stock on a 2-to-one basis;
all of 34,129,398 shares of Legacy Evolv’s Series B-1 convertible preferred stock were converted into an equivalent number of shares of Legacy Evolv common stock on a 1-to-one basis; and
all of 15,367,312 shares of Legacy Evolv’s Series B convertible preferred stock were converted into an equivalent number of shares of Legacy Evolv common stock on a 1-to-one basis.

On the closing date of the Merger, each share of Legacy Evolv common stock then issued and outstanding was canceled and the holders thereof in exchange received 94,192,534 shares of the Company’s financial statements with another public companycommon stock, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible becauseequal to 0.378 newly-issued shares of the potential differencesCompany’s common stock for each share of Legacy Evolv common stock (the “Exchange Ratio”).

All outstanding warrants exercisable for common stock in accounting standards used.

Cash and Cash Equivalents:

The Company considers all highly liquid instruments with original maturities of three monthsLegacy Evolv (other than warrants that expired, were exercised or less when acquired,were deemed automatically net exercised immediately prior to be cash equivalents.  The Company had no cash equivalents at March 31, 2021.

Deferred Offering Costs:

The Company compliesthe Merger) were exchanged for warrants exercisable for the Company’s common stock with the requirementssame terms and conditions except adjusted by the Exchange Ratio.

All outstanding stock options of Legacy Evolv common stock, totaling 57,938,375 stock options, were canceled and the holders thereof in exchange received options to receive 0.378 shares of the FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (SAB) Topic 5A — “ExpensesCompany’s common stock for a total of Offering.” Costs incurred in connection with preparation for the Offering were approximately $9,986,000, including underwriters’ discount paid and deferred of approximately $9,488,000. Such costs were allocated among the equity and warrant liability components based on the relative fair value21,891,254 stock options. The modification of the warrants and approximately $9,596,000 has been chargedstock options to equity forreflect the equity components and approximately $390,000 has been chargedexchange ratio did not result in an incremental compensation expense upon closing of the Merger.

F-10

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Prior to other expense for the warrant liability components upon completion of the Public Offering.


Redeemable Common Stock:

As discussed in Note 3, allMerger, the Company entered into subscription agreements (collectively, the “PIPE Investment”) with certain parties subscribing for shares of the 17,250,000 public shares sold as part of Units inCompany’s common stock (the “Subscribers”) pursuant to which the Public Offering contain a redemption feature which allows forSubscribers agreed to purchase. Pursuant to the redemption of public shares ifPIPE Investment, the Company holdsissued 30,000,000 shares of common stock for a stockholder vote or there is a tender offer for shares in connectionpurchase price of $10.00 per share with a Business Combination. In accordance with FASB ASC 480, redemption provisions not solely within the controlgross proceeds of the Company require the security to be classified outside$300.0 million.

The proceeds, net of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excludedredemptions, received from the provisions of FASB ASC 480. AlthoughMerger were $84.9 million and gross proceeds received from the Company did not specify a maximum redemption threshold, its charter provides that in no event will it redeem its public shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001 uponPIPE investment were $300.0 million. Based on the closing of a Business Combination.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the securities at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by adjustments to additional paid-in capital. Accordingly, at March 31, 2021 and December 31, 2020, 13,669,161 and 14,077,350, respectively, of the 17,250,000 public shares were classified outside of permanent equity.

Net Income (Loss) per Share

Net income (loss) per common share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding on July 16, 2021 (in each case, not giving effect to any shares issuable upon exercise of warrants, options, or earn-out shares), Legacy Evolv shareholders owned approximately 92.7% of the common stock of the Company and NHIC shareholders owned approximately 7.3%.

4. Fair Value Measurements

The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):

Fair Value Measurements at March 31, 2022

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

Money market funds

$

257,555

$

$

$

257,555

$

257,555

$

$

$

257,555

Liabilities:

  

 

  

 

  

 

  

Contingent earn-out liability

$

$

$

18,128

$

18,128

Contingently issuable common stock liability

3,792

3,792

Public Warrant liability

5,444

5,444

$

$

$

27,364

$

27,364

Fair Value Measurements as of December 31, 2021

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

Money market funds

$

297,536

$

$

$

297,536

$

297,536

$

$

$

297,536

Liabilities:

  

 

  

 

  

 

  

Contingent earn-out liability

$

$

$

20,809

$

20,809

Contingently issuable common stock liability

5,264

5,264

Public Warrant liability

11,030

11,030

$

$

$

37,103

$

37,103

As of March 31, 2022 and December 31, 2021, respectively, money market funds are included in cash and cash equivalents on the condensed consolidated balance sheets.

During the three months ended March 31, 2022 and 2021, respectively, there were 0 transfers between Level 1, Level 2 and Level 3.

Valuation of Contingent Earn-out

Pursuant to the Merger Agreement, the Legacy Evolv shareholders, immediately prior to the Merger, were entitled to receive additional shares of the Company’s common stock upon the Company achieving certain milestones as described in Note 2 of our consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2021. The Company’s contingent earn-out shares were recorded at fair value as contingent earn-out

F-11

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

liability upon the closing of the Merger and are remeasured at each reporting period. As of March 31, 2022, 0 milestones have been achieved.

The estimated fair value of the initial contingent earn-out was determined using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the earn-out period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. As of March 31, 2022, the contingent earn-out was revalued using a similar Monte Carlo analysis. The significant assumptions to the model as of December 31, 2021 were as follows: 55% expected stock price volatility, a drift rate of 1.2%, 25% likelihood of change in control and an expected term of 4.5 years. The significant assumptions to the model as of March 31, 2022 were as follows: 92.5% expected stock price volatility, a drift rate of 2.4%, 25% likelihood of change in control and an expected term of 4.3 years.

The following table provides a rollforward of the contingent earn-out liability (in thousands):

Balance at December 31, 2021

$

20,809

Change in fair value

 

(4,226)

Out-of-period adjustment

1,545

Balance at March 31, 2022

$

18,128

Valuation of Contingently Issuable Common Stock

Prior to the Merger, certain NHIC shareholders owned 4,312,500 Founder Shares. 1,897,500 shares vested at the closing of the Merger, 517,500 shares were transferred back to NHIC and then contributed to Give Evolv LLC and the remaining 1,897,500 outstanding shares shall vest upon the Company achieving certain milestones as described in Note 2 of our consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2021. The Company’s contingently issuable common stock was recorded at fair value as contingent shares on the closing of the Merger and will be remeasured at each reporting period. As of March 31, 2022, 0 milestones have been achieved.

The estimated fair value of the initial contingently issued common shares was determined using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the vesting period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. As of March 31, 2022, the contingently issuable common shares were revalued using a similar Monte Carlo analysis. The significant assumptions to the model as of December 31, 2021 were as follows: 55% expected stock price volatility, a drift rate of 1.2%, 25% likelihood of change in control and an expected term of 4.5 years. The significant assumptions to the model as of March 31, 2022 were as follows: 92.5% expected stock price volatility, a drift rate of 2.4%, 25% likelihood of change in control and an expected term of 4.3 years.

The following table provides a rollforward of the contingently issuable common shares (in thousands):

Balance at December 31, 2021

$

5,264

Change in fair value

 

(1,472)

Balance at March 31, 2022

$

3,792

Valuation of Public Warrant Liability

Upon the closing of the Merger, the Company assumed the Public Warrants to purchase shares of the Company’s common stock (see Note 13). The Public Warrants are publicly traded and the initial fair value of the public warrants were based on the closing price as reported by Nasdaq on the date of the Merger and remeasured at each reporting period.

F-12

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table provides a rollforward of the public warrant liability (in thousands):

Balance at December 31, 2021

$

11,030

Change in fair value

 

(5,586)

Balance at March 31, 2022

$

5,444

5. Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification 606 – Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In order to achieve this core principle, the Company applies the following five steps when recording revenue: (1) identify the contract, or contracts, with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when, or as, performance obligations are satisfied.

The Company derives revenue from (1) subscription arrangements generally accounted for as operating leases under ASC 842 and (2) from the sale of products, inclusive of SaaS and maintenance and (3) professional services. The Company’s arrangements are generally noncancelable and nonrefundable after ownership passes to the customer for product sales and upon installation for subscriptions. Revenue is recognized net of sales tax.

Remaining Performance Obligations

The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially satisfied) as of March 31, 2022.

    

Less than 1 year

    

Greater than 1 year

    

Total

Product revenue

 

$

166

 

$

39

 

$

205

Subscription revenue

 

12,784

 

29,041

 

41,825

Service revenue

 

6

6

Maintenance revenue

2,415

6,086

8,501

Total revenue

$

15,371

$

35,166

$

50,537

The amount of minimum future leases is based on expected income recognition. As of March 31, 2022, future minimum payments on noncancelable leases are as follows (in thousands):

Future operating lease component:

    

  

Year Ending December 31:

2022 (nine months remaining)

$

9,677

2023

 

12,330

2024

 

11,137

2025

 

7,438

2026

1,131

Thereafter

 

112

$

41,825

Contract Balances from Contracts with Customers

Contract assets arise from unbilled amounts in customer arrangements when revenue recognized exceeds the amount billed to the customer and the Company’s right to payment is conditional and not only subject to the passage of

F-13

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

time. As of March 31, 2022 and December 31, 2021, the Company had $1.4 million and $1.5 million in current portion of contract assets and $3.3 million and $3.4 million in contract assets, noncurrent on the condensed consolidated balance sheets, respectively.

Contract liabilities represent the Company’s obligation to transfer goods or services to a customer for which it has received consideration (or the amount is due) from the customer. The Company has a contract liability related to service revenue, which consists of amounts that have been invoiced but that have not been recognized as revenue. Amounts expected to be recognized as revenue within 12 months of the balance sheet date are classified as current deferred revenue and amounts expected to be recognized as revenue beyond 12 months of the balance sheet date are classified as deferred revenue, noncurrent. The Company recognized $2.5 million during the three months ended March 31, 2022 of revenue that was previously included in the 2021 deferred revenue balance and recognized $0.9 million during the three months ended March 31, 2021 of revenue that was previously included in the 2020 deferred revenue balance.

The following table provides a rollforward of deferred revenue (in thousands):

Balance at December 31, 2021

$

9,165

Revenue recognized

 

(6,409)

Revenue deferred

 

9,194

Balance at March 31, 2022

$

11,950

The following table presents the Company’s components of lease revenue (in thousands):

Three Months Ended March 31, 

2022

2021

Revenue from sales-type leases

$

1,312

$

Interest income on lease receivables

190

 

Lease income - operating leases

3,020

1,300

Total lease revenue

$

4,522

$

1,300

The revenue from sales-type leases is related to the Evolv Express units where the lease term is for the major part of the economic life of the underlying equipment and is classified as product revenue in the condensed consolidated statements of operations and comprehensive loss. The interest income on lease receivables is classified as other income (expense), net in the condensed consolidated statements of operations and comprehensive loss. The lease income from operating leases is related to the leased equipment under subscription arrangements and is classified as subscription revenue in the condensed consolidated statements of operations and comprehensive loss.

Disaggregated Revenue

The following table presents the Company’s revenue by revenue stream (in thousands):

Three Months Ended March 31, 

2022

    

2021

Product revenue

5,194

 

2,502

Leased equipment

3,020

 

1,300

SaaS and Maintenance revenue

353

 

132

Professional services revenue

148

65

Total revenue

$

8,715

$

3,999

F-14

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Contract Acquisition Costs

The Company incurs and pays commissions on product sales. The Company applies the practical expedient for contracts less than one year to expense the commission costs in the period in which they were incurred. Commissions on product sales and services are expensed in the period in which the related revenue is recognized. Commissions on subscription arrangements and maintenance are expensed ratably over the life of the contract. The Company had a deferred asset related to commissions of $5.7 million and $5.4 million as of March 31, 2022 and December 31, 2021, respectively. The Company amortized commissions of $0.1 million during the three months ended March 31, 2022 which related to 2022 commissions and $0.3 million which related to 2021 commissions.

Give Evolv LLC

Upon the closing of the Merger, the NHIC Founders transferred 517,500 shares of its common stock to Evolv NewHold Benefit LLC (“ENHB”), which represented the initial contribution to be used to pay for the donation of Evolv’s Express units to public venues and institutions, primarily schools in locations that might not otherwise be able to afford weapon detection security screening systems and related products and services. In September 2021, ENHB was renamed to Give Evolv LLC (“Give Evolv”). Give Evolv is deemed an entity under common control and a consolidating entity as it is under the same management as the Company. As such, the shares held by Give Evolv are not considered outstanding or issued.

For such arrangements, Give Evolv generally purchases the effectrelated products and services from Evolv Technologies, Inc. through an intercompany transaction using the available donated proceeds from the transfer of common stock upon the closing of the warrants soldMerger. Evolv Technologies, Inc. will be responsible for the delivery of the units, in addition to providing related services, such as installation, training, and maintenance. Consideration transferred to Evolv Technologies, Inc. for the related products and services may be in the Public Offering and Private Placement to purchase an aggregateform of 14,325,000 shares of Class A common stock or cash. Shares of common stock may be sold to generate funds for the purposes of paying for the donated goods and services. The sales transactions between Evolv Technologies, Inc. and Give Evolv eliminate in consolidation.

During the three months ended March 31, 2022, the Company donated 3 Evolv Express units to schools, resulting in $0.2 million in general and administrative expense in the calculationCompany’s condensed consolidated statements of diluted income (loss) peroperations and comprehensive loss.

6. Leases

Company Headquarters (Waltham, MA)

In April 2021, the Company entered a sublease agreement for office and storage space for its corporate headquarters located at 500 Totten Pond Road in Waltham, MA. The sublease has an initial term of 42 months beginning on May 1, 2021, and expiring on October 31, 2024. The Company is required to maintain a minimum cash balance of $0.7 million as a security deposit on the space which is classified as restricted cash, current and restricted cash, non-current on the condensed consolidated balance sheets. The Company pays for its proportionate share since their inclusion would be anti-dilutiveof building operating expenses and taxes that are treated as variable costs and excluded from the measurement of the lease. The sublease grants the Company an option to extend the term for an additional three years at the then fair market rent by giving the landlord nine months’ written notice. The Company was not reasonably certain to exercise the option to extend the lease and therefore the extension term was excluded from the measurement of the lease.

Storage Facilities

The Company additionally leases 3 storage spaces on a month-to-month basis that are classified as short-term leases.

F-15

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables contains a summary of the lease costs recognized under ASC 842 and other information pertaining to the treasury stock method. As a result, diluted income (loss) per common share is the same as basic loss per common shareCompany’s operating leases for the period.three months ended March 31, 2022.

The Company’s statementcomponents of operations includes a presentationlease cost under ASC 842 were as follows (in thousands):

Operating lease cost

 

$

245

Supplemental disclosure of income (loss) per share for common stock subjectcash flow information related to redemption in a manner similar to the two-class methodleases was as follows (in thousands):

Cash paid for amounts included in the measurement of lease liabilities

 

$

278

The weighted-average remaining lease term and discount rate were as follows:

Weighted average remaining lease term (in years)

2.6

Weighted average discount rate

6.95

%

Future annual lease payments under non-cancelable operating leases as of income (loss) per share. Net income (loss) per share, basic and diluted for Class A common stock is calculated by dividing the interest income earned on the funds in the Trust Account, net of income tax expense and franchise tax expense, by the weighted average number of shares of Class A common stock outstanding since their original issuance. Net income (loss) per common share, basic and diluted, for shares of Class B common stock is calculated by dividing the net income (loss), less income attributable to Class A common stock, by the weighted average number of shares of Class B common stock outstanding for the period. Net income (loss) available to each class of common stockholders isMarch 31, 2022 were as follows (in thousands):

Year Ended December 31:

 

2022 (remaining nine months)

 

$

838

2023

1,149

2024

982

Total future lease payments

$

2,969

Less: imputed interest

(246)

Present value of operating lease liability

$

2,723

Rent expense for the three months ended March 31, 2021 andwas approximately $0.1 million in accordance with ASC 840. Rent expense for the period from January 24, 2020 (dateyear ended December 31, 2021 was approximately $0.9 million in accordance with ASC 840.

Future annual lease payments under non-cancelable operating leases as of inception) toDecember 31, 2021 under ASC 840 were as follows (in thousands):

Year Ended December 31:

 

2022

 

$

1,116

2023

1,150

2024

981

Total

$

3,247

7. Accounts Receivable

Allowance for Doubtful Accounts

As of March 31, 2020:2022 and December 31, 2021, the Company’s allowance for doubtful accounts of $0.1 million, respectively. Changes in the allowance for doubtful accounts were as follows (in thousands):

  

Three months

Ended

March 31, 2021

  

For the Period

From January 24,

2020 (date of

inception) to

March 31, 2020

 
Net income available to Class A common stockholders:      
Interest income $19,000  $- 
Less:  Income and franchise taxes  (19,000)  - 
Net income attributable to Class A common stockholders $-  $- 
Net income available to Class B common stockholders:        
Net loss $(4,082,000) $(2,000)
Less: amount attributable to Class A common stockholders  -   - 
Net (loss) attributable to Class B common stockholders $(4,082,000) $(2,000)


F-16

ConcentrationTable of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Allowance for Doubtful Accounts

Balance at December 31, 2021

$

(50)

Provisions

0

Write-offs, net of recoveries

0

Balance at March 31, 2022

$

(50)

8. Inventory

Inventory consisted of the following (in thousands):

March 31, 

December 31, 

    

2022

    

2021

Raw materials

$

1,172

$

1,050

Finished goods

 

6,009

 

4,090

Total

$

7,181

$

5,140

9. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

 

March 31, 

December 31, 

 

2022

    

2021

Prepaid deposits

$

13,479

$

7,591

Prepaid insurance

1,625

2,803

Prepaid subscriptions

625

411

Other

 

1,523

 

242

Total

$

17,252

$

11,047

10. Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

March 31, 

December 31, 

2022

    

2021

Computers and telecom equipment

$

329

$

40

Lab equipment

 

568

 

568

Purchased software

 

59

 

Furniture and fixtures

 

37

 

37

Leasehold improvements

 

538

 

491

Leased equipment

24,217

21,100

Internal-use software

1,820

1,029

Sales demo equipment

 

2,149

 

1,938

 

29,717

 

25,203

Less: Accumulated depreciation and amortization

 

(4,435)

 

(3,611)

$

25,282

$

21,592

As of March 31, 2022 and December 31, 2021, the net book value of internal-use software was $1.7 million and $1.0 million, respectively. Depreciation expense and amortization expense related to property and equipment was $0.9 million and $0.5 million for the three months ended March 31, 2022 and 2021, respectively, which included amortization expense of internal-use software of less than $0.1 million and $0 for the three months ended March 31, 2022 and 2021, respectively.

F-17

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Leased equipment and the related accumulated depreciation were as follows (in thousands):

March 31, 

December 31, 

2022

    

2021

Leased equipment

$

24,217

$

21,100

Accumulated depreciation

 

(3,390)

 

(2,761)

Leased equipment, net

$

20,827

$

18,339

Depreciation related to leased units was $0.8 million and $0.4 million during the three months ended March 31, 2022 and 2021, respectively. Depreciable lives generally range from 4 to 7 years, consistent with the Company’s planned and historical usage of the equipment subject to operating leases.

Impairment of property and equipment was $0.1 million for the three months ended March 31, 2022. There was 0 impairment recognized for the three months ended March 31, 2021. This related to Edge units and Express prototype units that were removed from service and retired. The Company is transitioning its domestic customers from the Edge units to the most current Express units, which also resulted in an impairment of the remaining economic value of such assets.

11. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

March 31, 

December 31, 

2022

    

2021

Accrued employee compensation and benefits expense

$

2,198

$

5,536

Accrued professional services and consulting

 

1,438

 

1,441

Accrued sales tax

1,213

1,091

Accrued marketing

521

Accrued property tax

472

Accrued interest

48

64

Other

 

1,228

 

1,051

Total

$

7,118

$

9,183

12. Long-term Debt

The components of the Company’s long-term debt consisted of the following (in thousands):

March 31, 

December 31, 

2022

    

2021

Term loans payable

$

10,000

$

10,000

Less: Unamortized discount

 

(50)

 

(55)

 

9,950

 

9,945

Less: Current portion of long-term debt

 

3,000

 

2,000

Long-term debt, net of discount

$

6,950

$

7,945

F-18

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Term Loan Agreements

JPMorgan Chase Bank, N.A.(“JPM”) Credit Risk:Agreement

Financial instruments that potentially subjectIn December 2020, the Company to concentrationsentered into a $10.0 million credit agreement with JPMorgan Chase Bank, N.A. (“JPM Credit Agreement”) with a maturity date of December 3, 2024 and a revolving line of credit risk consist of cash accounts inup to $10.0 million with a financial institution, whichmaturity date of December 3, 2022.

Principal and interest on the JPM Credit Agreement is payable monthly commencing on July 1, 2022. The JPM Credit Agreement accrues interest at times, may exceedan annual rate calculated as the Federal depository insurance coveragegreater of $250,000.(A) the Wall Street Journal Prime Rate plus 2.25% or (B) 5.5%. The Company has not experienced losses on these accounts and management believesrevolving line of credit accrues interest at an annual rate calculated as the greater of (A) the Wall Street Journal Prime Rate plus 1.25% or (B) 4.5%. Upon closing, the Company is not exposedissued warrants to significant risks on such accounts.

Financial Instruments:

Thepurchase 377,837 shares of common stock to the lender with an exercise price of $0.42 per share with a fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC 820”), “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the financial statements.

Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at$0.1 million on the date of the financial statements. Making estimates requires managementissuance. The Company incurred debt issuance costs of $0.1 million equal to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subjectwarrants in connection with the JPM Credit Agreement. These costs were recorded as debt discount and are amortized to change as moreinterest expense, using the effective interest method, over the term of the loan. Upon the closing of the Merger, the warrants were converted into shares of the Company’s common stock.

As of March 31, 2022, the unamortized debt discount was $0.1 million. As of March 31, 2022, the accrued interest on the JPM Credit Agreement was $0.1 million, which is included in accrued expenses and other current information becomes availableliabilities in the condensed consolidated balance sheet. Interest expense related to the JPM Credit Agreement totaled $0.1 million and accordingly the actual results could differ significantly from those estimates.

Income Taxes:

The Company follows the asset and liability method of accounting for income taxes under FASB ASC, 740, “Income Taxes.” Deferred tax assets and liabilities are recognized$0.2 million for the estimated future tax consequences attributable to differences betweenthree months ended March 31, 2022 and 2021, respectively, which includes the financial statements carrying amountsamortization of existing assetsthe debt discount which totaled less than $0.1 million and liabilities$0.1 million for the three months ended March 31, 2022 and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income2021, respectively. The interest rate in effect as of March 31, 2022 was 5.75% for the years in which those temporary differences are expected to be recovered or settled. The effectJPM Credit Agreement. During the year ended December 31, 2021, the Company fully repaid the $5.4 million drawn down on deferred tax assets and liabilitiesthe revolving line of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

credit.

The Company’s currently taxable income consistsobligations under the JPM Credit Agreement are secured by a first-priority security interest in all of its assets, including intellectual property.

As of March 31, 2022, future principal payments on long-term debt are as follows (in thousands):

Year Ending December 31,

    

2022 (remaining nine months)

$

2,000

2023

 

4,000

2024

 

4,000

$

10,000

Convertible Note

In September 2020, the Company entered into a Convertible Note Purchase Agreement (the “2020 Convertible Notes”) with an investor for gross proceeds of $2.0 million with a stated interest incomerate of 6.0% per annum. An additional $2.0 million in gross proceeds were made available in December 2020 upon achievement of the integration milestone, whereby the Company successfully created software utilizing the investor’s application programming interface. The 2020 Convertible Notes provided a conversion option whereby upon the closing of a Qualified Financing event, in which the aggregate gross proceeds of the issuance of preferred stock totaled at least $10.0 million, the notes would automatically convert into shares of the same class and series of capital stock of the Company issued to other investors in the financing at a conversion price equal to 80% of the price per share paid by the other investors. The conversion option met the definition of an embedded derivative and was required to be bifurcated and accounted for separately from the notes. The proceeds from the 2020 Convertible Notes were allocated between the derivative liability, with a fair value at issuance of $1.0 million, and the notes, with an initial carrying value of $3.0 million, and included in long-

F-19

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

term liabilities on the Trust AccountCompany’s condensed consolidated balance sheet. The difference between the initial carrying value of the notes and the stated value of the notes represented a discount that was accreted to interest expense over the term of the Convertible Notes using the effective interest method. This derivative liability was derecognized as of December 31, 2021 as the liability was settled pursuant to the closing of the Merger.

Interest expense for the 2020 Convertible Notes totaled $0 and $0.1 million for the three months ended March 31, 2022 and 2021, respectively.

In January and February 2021, the Company entered into a Convertible Note Purchase Agreement (the “2021 Convertible Notes”) with various investors for gross proceeds of $30.0 million with a stated interest rate of 8.0% per annum. The 2021 Convertible Notes provided a conversion option whereby upon the closing of a Qualified Financing event, in which the aggregate gross proceeds totaled at least $100.0 million, the notes would automatically convert into shares of the same class and series of capital stock of the Company issued to other investors in the financing at a conversion price equal to 80% of the price per share paid by the other investors. The conversion option met the definition of an embedded derivative and was required to be bifurcated and accounted for separately from the notes. The proceeds from the 2021 Convertible Notes were allocated between the derivative liability, with a fair value at issuance of $7.0 million, and the notes, with an initial carrying value of $23.0 million, and included in long-term liabilities on the Company’s condensed consolidated balance sheet. The difference between the initial carrying value of the notes and the stated value of the notes represented a discount that was accreted to interest expense over the term of the Convertible Notes using the effective interest method. This derivative liability was derecognized as of December 31, 2021 as the liability was settled pursuant to the closing of the Merger.

In June 2021, the Company modified the 2021 Convertible Notes to grant the holders an additional 1,000,000 shares of NHIC common stock as further consideration upon the automatic conversion of the notes upon closing of the Merger. This modification of the notes resulted in an extinguishment and the Company recognized a loss on extinguishment of the 2021 Convertible Notes of $11.8 million. The $26.7 million carrying value of the notes at June 21, 2021 was derecognized and replacement notes with an initial carrying value of $29.6 million were recorded. Additionally, in the extinguishment accounting, a derivative liability of $19.2 million was recognized, which represents the value of the 1,000,000 NHIC shares as well as a bifurcated embedded derivative for the conversion option.

Upon the closing of the Merger, the Convertible Notes automatically converted into 4,408,672 shares of the Company’s common stock and the holders of the 2021 Convertible Notes also received the right to receive 1,000,000 shares of the Company’s common stock, as noted above. Upon the conversion of the Convertible Notes, the carrying value of the debt of $32.8 million, and the related derivative liability of $19.7 million and accrued interest of $0.2 million were derecognized resulting in a loss on extinguishment of debt of $0.9 million recorded in other income (expense).

Interest expense for the 2021 Convertible Notes totaled $0 and $1.9 million for the three months ended March 31, 2022 and 2021, respectively.

13. Warrants

In January 2021, in connection with a Business Development Agreement entered into with Finback Evolv II, LLC (“Finback BDA”), the Company issued a warrant to Finback for the purchase of 2,552,913 shares of common stock at an exercise price of $0.42 per share. The 2021 Finback common stock warrants vest upon meeting certain sales criteria as defined in the agreement and expires in January 2031. The warrants will be accounted for under ASC 718 Compensation – Stock Compensation as the warrants will vest upon certain performance conditions being met (see Note 16).

In connection with the closing of the Merger, the Company assumed the Public Warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50. The Public Warrants are immediately exercisable and expire in July 2026. The Public Warrants are classified as a liability and were recorded at its fair value of $23.6 million

F-20

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

on the date of the closing of the Merger with an offset to additional paid-in-capital and is subsequently remeasured to fair value at each reporting date based on the publicly available trading price. The change in fair value of the public warrant liability of $5.6 million and $0 was recognized as a component of other income (expense), net in the condensed consolidated statements of taxes. Theoperations and comprehensive loss for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, none of the vested 2021 Finback common stock warrants were exercised.

As of March 31, 2022 and December 31, 2021, warrants to purchase the following class of Common stock outstanding consisted of the following in the tables below:

March 31, 2022

Contractual

Shares Issuable

Weighted

Term

Underlying Equity

Balance Sheet

Upon Exercise

Average

Issuance Date

    

(in years)

    

Instrument

    

Classification

    

of Warrant

    

Exercise Price

January 13, 2021

 

10

 

Common stock

 

Equity

 

2,552,913

$

0.42

July 16, 2021

 

5

 

Common stock

 

Liability

 

14,324,993

$

11.50

 

  

 

  

 

16,877,906

 

  

December 31, 2021

Contractual

Shares Issuable

Weighted

Term

Underlying Equity

Balance Sheet

Upon Exercise of

Average

Issuance Date

    

(in years)

    

Instrument

    

Classification

    

Warrant

    

Exercise Price

January 13, 2021

 

10

 

Common stock

 

Equity

 

2,552,913

$

0.42

July 16, 2021

 

5

 

Common stock

 

Liability

 

14,324,994

$

11.50

 

  

 

  

 

16,877,907

 

  

14. Convertible Preferred Stock

Prior to the Merger, Legacy Evolv had issued Series A convertible preferred stock (“Series A Preferred Stock”), Series A-1 convertible preferred stock (“Series A-1 Preferred Stock”), Series B convertible preferred stock (“Series B Preferred Stock”), and Series B-1 convertible preferred stock (“Series B-1 Preferred Stock”), collectively referred to as the “Preferred Stock”.

Pursuant to the Merger Agreement, immediately prior to the Merger, each share of Legacy Evolv’s Series A-1, Series B-1, and Series B preferred stock outstanding converted to Legacy Evolv common stock on a 1:1 conversion ratio. Pursuant to the Merger Agreement, immediately prior to the Merger, each share of Legacy Evolv’s Series A preferred stock outstanding converted to Legacy Evolv common stock on a 2:1 conversion ratio. On the closing date of the Merger, each share of Legacy Evolv common stock then issued and outstanding was canceled and the holders thereof in exchange received shares of Evolv Technologies Holdings, Inc. equal to 0.378 shares for each share of Legacy Evolv common stock. As of December 31, 2021, the Company has 0 preferred stock outstanding as all convertible preferred stock converted to common stock upon closing of the Merger.

15. Common Stock

As of March 31, 2022 and December 31, 2021, the Company had reserved 74,863,862 and 76,008,377 shares, respectively, of common stock for the conversion of the outstanding Preferred Stock, exercise of outstanding stock options, granting of awards under the Company’s general2021 Equity Incentive Plan and administrative costs2013 Equity Incentive Plan (see Note 16) and the exercise of outstanding warrants (see Note 13).

F-21

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

16. Stock-Based Compensation

2021 Equity Incentive Plan

As of March 31, 2022 and December 31, 2021, shares of common stock that may be issued under the 2021 Plan were 21,177,295. As of March 31, 2022 and December 31, 2021, 11,938,665 and 19,511,916 shares remained available for future grant under the 2021 Plan. Shares that are generally considered start-up costs andexpired, forfeited, canceled or otherwise terminated without having been fully exercised will be available for future grant under the 2021 Plan. In addition, shares of common stock that are not currently deductible. tendered to the Company by a participant to exercise an award are added to the number of shares of common stock available for future grants.

During the three months ended March 31, 2021 and the period from January 24, 2020 (date of inception) to March 31, 2020,2022, the Company recorded income tax expense of approximately $-0- for both periods, respectively, related to interest income earned on the Trust Account net of taxes. The Company’s effective tax rate for the three months ended March 31, 2021 and the period from January 24, 2020 (date of inception) to March 31, 2020 was approximately -0 -%, for both periods which differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible as well as business combination and warrant liability charges or credits which may not be deductible, and the low level of interest income. At March 31, 2021 and December 31, 2020, the Company has a deferred tax asset of approximately $550,000 and $200,000, respectively, primarily related to start-up and Business Combination costs. Management has determined that a full valuation allowance of the deferred tax asset is appropriate at this time.

FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at March 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Warrant Liability

granted 2,262,925 options.

The Company accounts for warrants as either equity-classified or liability-classified instruments basedfollowing table presents, on an assessment ofa weighted average basis, the warrant’s specific terms and applicable authoritative guidance FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.


For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and at fair value in each balance sheet date thereafter. Changesassumptions used in the estimatedBlack-Scholes option-pricing model to determine the grant-date fair value of stock options granted:

Three Months Ended March 31, 

 

    

2022

    

2021

 

Risk-free interest rate

 

1.6

%

0.5

%

Expected term (in years)

 

6.1

4.6

Expected volatility

 

75.0

%

23.9

%

Expected dividend yield

 

0.0

%

0.0

%

The following tables summarize the warrants are recognizedCompany’s stock option activity since December 31, 2021 (in thousands, except for share and per share data):

    

    

    

Weighted

    

Weighted

Average

Number of

Average

Remaining

Aggregate

Shares

Exercise Price

Contractual Term

Intrinsic Value

(in years)

Outstanding as of December 31, 2021

20,769,130

$

0.39

Granted

 

2,262,925

2.32

 

 

Exercised

 

(499,767)

0.42

 

Forfeited

(567,979)

0.42

 

 

Outstanding as of March 31, 2022

 

21,964,309

0.59

7.70

$

45,207

 

  

 

  

 

  

 

  

Vested and expected to vest as of March 31, 2022

 

21,964,309

$

0.59

 

7.70

$

45,207

Options exercisable as of March 31, 2022

 

12,025,749

$

0.38

 

6.77

$

27,356

The aggregate intrinsic value of options is calculated as a non-cash gain or loss on the statementsdifference between the exercise price of operations. Costs associated with issuing the warrants accounted for as liabilities are charged to operations whenstock options and the warrants are issued. The fair value of the public warrants and the private placement warrants were initially estimated using a Monte Carlo simulation approach. Following the separate trading of the Company’s common stock and public warrants,for those options that had exercise prices lower than the private placement warrants fair values were estimated using a Black-Scholes-Merton approach.

Recent Accounting Pronouncements:

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt --Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Subsequent Events:

Management has evaluated subsequent events to determine if events or transactions occurring after the date of the financial statements but before the financial statements were available to be issued require potential adjustment to or disclosure in the financial statements and has concluded that all such events that would require adjustment or disclosure have been recognized or disclosed.

NOTE 4 – PUBLIC OFFERING

In August 2020, the Company closed on the Public Offering, including the full exercise of the underwriters’ overallotment option, of an aggregate 17,250,000 units at a price of $10.00 per unit (the “Units”). Each Unit consists of one sharevalue of the Company’s Class A common stock, $0.0001 par value and one-half of one redeemable warrant (the “Warrants”). Each whole Warrant offered in the Public Offering is exercisable to purchase one share of our Class A common stock for $11.50 per share. Only whole Warrants may be exercised. Under the terms of the warrant agreement, the Company has agreed to use its best efforts to file a new registration statement under the Securities Act,stock.

Restricted Stock Units

The following the completion oftable summarizes the Company’s initial Business Combination. No fractional shares will be issued upon exercise of the Warrants. If, upon exercise of the Warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of shares of Class A commonrestricted stock to be issued to the Warrant holder. Each Warrant will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Public Offering and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete its initial Business Combination on or prior to the 24-month period allotted to complete the Business Combination, the Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of Class A common stock to the holder upon exercise of a Warrant during the exercise period, there will be no net cash settlement of these Warrants and the Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the warrant agreement. Once the Warrants become exercisable, the Company may redeem the outstanding Warrants in whole and not in part at a price of $0.01 per Warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Company’s shares of Class A common stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the Warrant holders.units activity since December 31, 2021:

In addition, if the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them, as applicable, prior to such issuance) (the “newly issued price”), the exercise price of the Warrants and the Private Placement Warrants (as defined below) will be adjusted (to the nearest cent) to be equal to 115% of the newly issued price.

The Company paid an underwriting discount of 2.0% of the per Unit price to the underwriters at the closing of the Public Offering (an aggregate fee of $3,450,000 including the exercise of the underwriter’s overallotment option).


In addition, the Company expects to pay an underwriting commission of 3.5% of the per Unit price to the underwriters (an aggregate of approximately $6,038,000), which commission was deposited in the Trust Account at the closing of the Public Offering and will be released to the underwriters only upon and concurrently with completion of the Company’s initial Business Combination.

NOTE 5 – RELATED PARTY TRANSACTIONS

Founder Shares

In February 2020, the Sponsor purchased 4,312,500 shares of Class B common stock (the “Founder Shares”) for $25,000, or approximately $0.006 per share. In July 2020, the Sponsor transferred an aggregate of 867,500 founder shares, including to the following persons: (i) 32,500 founder shares to each of Marc Saiontz and Suzy Taherian, two of the Company’s independent director nominees, (ii) 35,000 founder shares to each of Neil Glat and Brian Mathis, two of the Company’s independent director nominees, (iii) 40,000 founder shares to Kathleen Harris, one of the Company’s independent director nominees, (iv) 50,000 founder shares to Thomas Sullivan, one of the Company’s independent director nominees, (v) 67,500 founder shares to Adam Deutsch, the Company’s Chief Financial Officer, (vi) 100,000 founder shares to Charlie Baynes-Reid, the Company’s Chief Operating Officer, (vii) 135,000 founder shares to each of Kevin Charlton and Charles Goldman, the Company’s Chief Executive Officer and director, respectively, and (viii) 200,000 founder shares to Nick Petruska, the Company’s special advisor; and (ii) the Sponsor forfeited 920,000 shares of Class B common stock and certain funds and accounts managed by Magnetar Financial LLC, UBS O’Connor LLC, and Mint Tower Capital Management B.V (collectively, the “Anchor Investor”) purchased 920,000 shares of Class B common stock from the Company for an aggregate purchase price of approximately $5,333, or approximately $0.006 per share resulting in the Company’s initial stockholders holding an aggregate of 4,312,500 Founder Shares. The Founder Shares are identical to the Class A common stock included in the Units being sold in the Public Offering except that the Founder Shares automatically convert into shares of Class A common stock at the time of the initial Business Combination and are subject to certain transfer restrictions, as described in more detail below.

The Company’s initial stockholders and Anchor Investors have agreed not to transfer, assign or sell any of its Founder Shares until the earlier of (A) one year after the completion of the Company’s initial Business Combination, or (B), subsequent to the Company’s initial Business Combination, if (x) the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the initial Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.

Private Placement Warrants

The Sponsor and the Anchor Investors purchased from the Company an aggregate of 5,700,000 warrants at a price of $1.00 per warrant, a purchase price of $5,700,000 in a private placement that occurred simultaneously with the completion of the Public Offering (the “Private Placement Warrants”), including the underwriters’ full exercise of their overallotment option. Each Private Placement Warrant entitles the holder to purchase one share of Class A common stock at $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from the Public Offering held in the Trust Account pending completion of the Company’s initial Business Combination. The Private Placement Warrants (including the Class A common stock issuable upon exercise of the Private Placement Warrants) are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination and they will be non-redeemable so long as they are held by the Sponsor or the Anchor Investors or their permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or the Anchor Investors or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the Units being sold in the Public Offering. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the Warrants being sold as part of the Units in the Public Offering and have no net cash settlement provisions.

If the Company does not complete a Business Combination, then the proceeds from the sale of the Private Placement Warrants will be part of the liquidating distribution to the public stockholders and the Private Placement Warrants issued to the Sponsor will expire worthless.

11

F-22

Table of Contents

Registration RightsEVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Number of

Grant Date Fair

Shares

Value

Outstanding as of December 31, 2021

1,951,924

$

6.76

Granted

 

4,425,142

 

3.50

Vested

 

(80,044)

 

7.95

Canceled

 

(46,020)

 

5.92

Outstanding as of March 31, 2022

 

6,251,002

$

4.44

The Company’s initial stockholders and the holders of the Private Placement Warrants will be entitled to registration rights pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the Public Offering. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements. There will be no penalties associated with delays in registering the securities under the proposed registration rights agreement.

Related Party Loans

In February 2020, the Sponsor agreed to loan the Company an aggregate of $300,000 by drawdowns of not less than $10,000 each against the issuance of an unsecured promissory note (the “Note”) to cover expenses related to the Public Offering. The Note was non-interest bearing and payable promptly after the earlier of the date on which the Company consummates the Public Offering and the date on which the Company determines not to conduct the Public Offering. The Company drew down a total of approximately $47,000 under the Note, including approximately $3,000 for costs paid directly by the Sponsor. On August 4, 2020, the approximately $47,000 outstanding under the Note was fully repaid in connection with the closing of the IPO.

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2021 and December 31, 2020, no Working Capital Loans were outstanding.

Administrative Support Agreement

The Company has agreed to pay $15,000 a month for office space, utilities and secretarial and administrative support to an affiliate of the Sponsor. Services commenced on the date the securities were first listed on the Nasdaq Capital Market and will terminate upon the earlier of the consummation by the Company of an initial Business Combination or the liquidation of the Company. During the three months ended March 31, 2022, the Company issued 4,425,142 shares of restricted stock units with an aggregate grant-date fair value of $15.5 million under the 2021 approximately $45,000 was included in general and administrative expensesPlan. The terms of the RSU’s under the 2021 Plan allow for the administrative support fee.following vesting periods, which are determined on an individual basis on the date of grant:

NOTE 6 - TRUST ACCOUNT AND FAIR VALUE MEASUREMENT

(A) The Company compliesrestricted stock units will vest over four years from the Vesting Commencement Date, with FASB ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

Upon the closing25% of the Public Offeringrestricted stock units vesting on the first anniversary of the Vesting Commencement Date and the Private Placement,remaining restricted stock units vesting quarterly thereafter over the remaining three years, subject to the individual remaining a total of approximately $172,500,000 was deposited into the Trust Account. The proceedsService Provider (as defined in the Trust Account must be invested in either U.S. government treasury bills2021 Plan) through the applicable vesting date.

(B) The restricted stock units will vest over three years from the Vesting Commencement Date, with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, and that invest solely in U.S. government treasury obligations.


At March 31, 2021 the proceedsone third of the Trust Account were invested primarily in U.S. government treasury bills maturing in May 2021 yielding interest of less than 0.1% per year. The Company classifies its U.S. government treasury bills and equivalent securities as held-to-maturity in accordance with FASB ASC 320, “Investments – Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity U.S. government treasury bills are recorded at amortized costrestricted stock units vesting on the accompanying March 31,first anniversary of the Vesting Commencement Date and the remaining restricted stock units vesting annually thereafter over the remaining two years, subject to the individual remaining a Service Provider (as defined in the 2021 condensed balance sheet and adjusted forPlan) through the amortizationapplicable vesting date.

(C) The restricted stock units will vest over one year from the Vesting Commencement Date, with the full amount vesting on the first anniversary of discounts.the Vesting Commencement Date, subject to the individual remaining a Service Provider (as defined in the 2021 Plan) through the applicable vesting date.

Performance Stock Units

The following table presents information aboutsummarizes the Company’s assets that are measured atperformance stock units activity since December 31, 2021:

Number of

Grant Date Fair

Shares

Value

Outstanding as of December 31, 2021

$

Granted

 

934,000

 

2.65

Vested

 

 

Canceled

 

 

Outstanding as of March 31, 2022

 

934,000

$

2.65

During the three months ended March 31, 2022, the Company issued 934,000 shares of with an aggregate grant-date fair value of $2.5 million under the 2021 Plan. Based upon the terms of the award agreements, 50% of the applicable units shall vest on a recurring basis asJanuary 1, 2023, provided that the Company has achieved its annual bookings goal for fiscal year 2022; and the remaining 50% of the units shall vest on January 1, 2024 if and only if the 2022 fiscal year bookings goal was achieved and subject to the grantee’s continued service through the applicable vesting date.

2021 Employee Stock Purchase Plan

As of March 31, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Since all3,435,748 shares of the Company’s permitted investments atcommon stock were available for future issuance. The Company’s Board of Directors may from time to time grant or provide for the grant to eligible employees of options to purchase common stock under the 2021 Employee Stock Purchase Plan during a specific offering period. As of March 31, 2022, 0 offerings have been approved.

F-23

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Warrants to Non-Employee Service Provider

In January 2021, consistedin connection with a Business Development Agreement entered into with Finback Evolv II, LLC, the Company issued a warrant to Finback for the purchase of U.S. government treasury bills2,552,913 shares of common stock at an exercise price of $0.42 per share. The 2021 Finback common stock warrants vest upon meeting certain sales criteria as defined in the agreement and money market funds that invest onlyexpires in U.S. government treasury bills, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active marketsJanuary 2031. The warrants will be accounted for identical assets or liabilitiesunder ASC 718 Compensation – Stock Compensation as follows:

Description Carrying
value at
March 31, 2021
  Gross
Unrealized
Holding Gains
  Quoted Price
Prices in Active Markets (Level 1)
 
Assets:         
Cash and money market funds $1,000  $-  $1,000 
U.S. government treasury bills  172,597,000   4,000   172,601,000 
Total $172,598,000  $4,000  $172,602,000 

NOTE 7 — ACCOUNTING FOR WARRANT LIABILITY

At March 31, 2021, there were 14,325,000the warrants outstanding including 8,625,000 Public Warrants and 5,700,000 Private Placement Warrants.

will vest upon certain performance conditions being met.

The Company accounts for its warrants outstanding consistent with the “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the “Staff Statement”) issued on April 12, 2021 by the staff (the “Staff”) of the Division of Corporation Finance of the SEC. The following table presents information about the Company’s warrant liabilities that are measured at fair value onutilized a recurring basis at March 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilizedBlack-Scholes pricing model to determine such fair value.

Description March 31,
2021
  Quoted Prices in
Active
Markets
(Level 1)
  Significant
Other
Observable
Inputs
(Level 2)
  Significant
Other
Unobservable
Inputs
(Level 3)
 
Warrant Liabilities:            
Public Warrants $14,317,000  $14,317,000  $  $- 
Private Placement Warrants  9,848,000         9,848,000 
Warrant liability at March 31, 2021 $24,165,000   14,317,000      $24,165,000 

The following table presents information about the Company’s warrant liabilities that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

Description December 31,
2020
  Quoted
Prices in
Active
Markets
(Level 1)
  Significant
Other
Observable
Inputs
(Level 2)
  Significant
Other
Unobservable
Inputs
(Level 3)
 
Warrant Liabilities:            
Public Warrants $12,851,000  $  $  $12,851,000 
Private Placement Warrants $8,668,000  $  $  $8,668,000 
Warrant liability at December 31, 2020 $21,519,000          $21,519,000 

The Company utilizes a third party valuation consultant that uses a Black-Scholes-Merton approach to value the Private Placement Warrants for the reporting period ended March 31, 2021, with changes in fair value recognized in the statement of operations. The estimatedgrant-date fair value of the Private Placement warrant liability2021 Finback common stock warrants granted. The assumptions used are presented in the following table:

Warrants - Black Scholes

Risk-free interest rate

0.4

%

Expected term (in years)

3.00

Expected volatility

23.9

%

Expected dividend yield

0.0

%

On the date of issuance, the total value of the 2021 Finback common stock warrants were valued as $19.5 million.

As of March 31, 2022, 341,094 shares of the 2021 Finback common stock warrants were exercisable at a total aggregate intrinsic value of $2.6 million. The remaining 2,211,819 shares of the 2021 Finback common stock warrants are unvested and have a total aggregate intrinsic value of $16.9 million. As of March 31, 2022, NaN of the 2021 Finback common stock warrants were exercised. The Company will recognize compensation expense for the 2021 Finback common stock warrants when the warrants become vested based on meeting the certain sales criteria. During the three months ended March 31, 2022 and 2021, the Company recorded $0.4 million and $0.8 million, respectively, of stock-based compensation expense within sales and marketing expense for the 2021 Finback common stock warrants.

Stock-Based Compensation

Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

Three Months Ended March 31, 

2022

    

2021

Cost of revenue

$

60

$

5

Sales and marketing

 

2,770

 

933

General and administrative

 

1,787

 

94

Research and development

 

573

 

50

Total stock-based compensation expense

$

5,190

$

1,082

Stock-based compensation expense was classified by award type in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

Three Months Ended March 31, 

2022

    

2021

Stock options

$

242

$

203

Earn-out shares

2,699

Warrants

436

807

Restricted stock units

1,813

72

Total stock-based compensation expense

$

5,190

$

1,082

F-24

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

17. Income Taxes

During the three months ended March 31, 2022 and 2021, the Company did 0t record income tax provisions or income tax benefits due to the net loss before income taxes expected to be incurred for the year ending December 31, 2022, as well as the Company’s continued maintenance of a full valuation allowance against its net deferred tax assets, and the net loss before income taxes incurred for the year ended December 31, 2021.

The Company’s tax provision and the resulting effective tax rate for interim periods is determined using Level 3 inputs. Inherentbased upon its estimated annual effective tax rate (“AETR”), adjusted for the effect of discrete items arising in that quarter. The impact of such inclusions could result in a Black-Scholes-Merton option pricing model are are assumptions related to expected share-price volatility, expected life, risk-free interesthigher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the annual effective tax rate, and dividend yield. if the estimated annual tax rate changes, a cumulative adjustment is made in that quarter.

18. Net Loss per Share

Basic and diluted net loss per share was calculated as follows (in thousands, except share and per share amounts):

Three Months Ended March 31, 

    

2022

    

2021

Numerator:

  

 

  

Net loss  – basic and diluted

$

(14,551)

$

(13,755)

 

 

Denominator:

 

 

Weighted average common shares outstanding — basic and diluted

142,878,406

10,443,323

Net loss - basic and diluted

$

(0.10)

$

(1.32)

The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:

Three Months Ended March 31, 

    

2022

    

2021

 

Options issued and outstanding

21,964,309

23,651,872

Public Warrants to purchase common stock

14,324,993

Convertible preferred stock (as converted to common stock)

80,833,007

Warrants to purchase preferred stock (as converted to warrants to purchase common stock)

1,014,963

Warrants to purchase common stock

922,297

Warrants to purchase common stock (Finback)**

2,552,913

2,552,913

Unvested restricted stock units

6,251,002

289,047

Unvested performance stock units

934,000

Earn-out shares**

15,000,000

Contingently issuable common stock**

1,897,500

Convertible notes (as converted to common stock)*

4,101,960

62,924,717

 

113,366,059

* Conversion feature is only triggered upon the closing of a Qualified Financing Event.

** Issuance of Earn-out shares, Contingently issuable common stock and Finback warrants are contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period.

F-25

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

19. Related Party Transactions

Nonrecourse Promissory Note with Officer

In August 2020, the Company estimatesentered into a $0.4 million promissory note with an officer with the volatilityproceeds being used to exercise options for 1,469,366 shares of its ordinarycommon stock at a price of $0.24 per share. The promissory note bore interest at the Wall Street Journal Prime Rate and was secured by the underlying shares basedof common stock that were issued upon the exercise of the stock options. The promissory note was treated as nonrecourse as the loan was only secured by the common stock issued from the exercise of the stock options. As such, (i) the underlying stock option grant was still considered to be outstanding and the shares of common stock were not considered issued and outstanding for accounting purposes until the loan was repaid in full or otherwise forgiven and (ii) no receivable was recorded for the promissory note on historical volatility that matches the expected remainingCompany’s condensed consolidated balance sheets. As such, the promissory note effectively extended the maturity date of the option grant for the life of the warrants.loan, this change is treated as a stock option modification. The risk-freeincremental fair value from the stock option modification was deemed immaterial. The interest rateon this nonrecourse loan is based onalso considered nonrecourse. As the U.S. Treasury zero-coupon yield curve onCompany has no intent to collect interest, 0 accrued interest was recorded.

In June 2021, the grant date for a maturity similarCompany agreed to repurchase 43,665 shares of common stock valued at $8.05 per share of common stock held by the expected remaining lifeofficer of the warrants. The expected lifeCompany. In exchange for the repurchase of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, whichcommon stock by the Company, anticipatesthe $0.4 million promissory note held by the officer was considered repaid in full.

Business Development Agreement with Finback

In March 2021, the Company granted a warrant exercisable for 2,552,913 shares of common stock to remain at zero.

The warrant liabilities are not subject to qualified hedge accounting.

There were no transfers between Levels 1, 2 or 3 duringFinback, a consulting group who is an affiliate of one of the periodCompany’s shareholders, with performance-based vesting conditions which vest upon certain sales being met under a Business Development agreement which has a term of three years. During the three months ended March 31, 2021.


The following table provides quantitative information regarding Level 3 fair value measurements:

  As of
March 31,
2021
  As of
December 31,
2020
 
Private Warrants:        
Term (in years)  5.0   5.0 
Volatility – pre announcement  10.0%  10.0%
Volatility – post announcement  22%  30%
Risk-free rate  1.04%  0.469%
Fair value of warrants $1.73  $1.52 
Public Warrants:        
Simulated warrant value   $1.49 
Publicly-traded value   $1.49 

The following table presents2022 and 2021, the changes inCompany recorded $0.4 million and $0.8 million, respectively, of stock-based compensation expense within sales and marketing expense for the fair value of warrant liabilities:

  Public  Private
Placement
  Warrant
Liabilities
 
          
Fair value measurement on December 31, 2020 $12,851,000  $8,668,000  $21,519,000 
Change in valuation inputs or other assumptions  1,466,000   1,180,000   2,646,000 
Fair value as of March 31, 2021 $14,317,000  $9,848,000  $24,165,000 

NOTE 8 – STOCKHOLDERS’ EQUITY

Common Stock

The authorized2021 Finback common stock of the Company is 50,000,000 shares, including 45,000,000 shares of Class A common stock, par value, $0.0001, and 5,000,000 shares of Class B common stock, par value, $0.0001. The Company may (depending on the terms of the Business Combination) be required to increase the authorized number of shares at the same time as its stockholders vote on the Business Combination to the extent the Company seeks stockholder approval in connection with its Business Combination. Holders of the Company’s Class A and Class B common stock vote together as a single class and are entitled to one vote for each share of Class A and Class B common stock they own. At March 31, 2021 and December 31, 2020, there were 4,312,500 shares of Class B common stock issued and outstanding at both dates and there were 3,580,839 and 3,172,650 shares, respectively, of Class A common stock issued and outstanding (excluding 13,669,161 and 14,077,350 shares, respectively, subject to possible redemption).

Preferred Stock

The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.

NOTE 9 – COMMITMENTS AND CONTINGENCIES

Business Combination Costs

warrants.

In connection with identifyingthe Merger and pursuant to the Merger Agreement, Finback is entitled to receive a proportional share of earn-out shares as an initial Business Combination candidateearn-out service provider, based upon the remaining unvested warrants as of the Merger Date. As of March 31, 2022 Finback can earn 280,410 earn-out shares subject to stock-based compensation, based on the achievement of certain milestones. During the three months ended March 31, 2022 and negotiating2021, the Company recorded $1.5 million and $0, respectively, of stock-based compensation expense within sales and marketing expense for the earn-out shares allocated to Finback.

Original Equipment Manufacturer Partnership Agreement with Motorola

In December 2020, the Company entered into an initial Business Combination,original equipment manufacturer partnership agreement (the “Distribution Agreement”) with Motorola, an investor in the Company. In June 2021, the partnership agreement was amended by the Amended and Restated Distribution Agreement (the “Amended and Restated Distribution Agreement”). Motorola sells Motorola-branded premium products based on the Evolv Express platform through their worldwide network of over 2,000 resellers and integration partners, and has integrated the Evolv Express platform with Motorola products. During the three months ended March 31, 2022 and 2021, revenue from Motorola’s distributor services was $0.8 million and $0, respectively. As of March 31, 2022 and December 31, 2021, accounts receivable related to Motorola’s distributor services was $1.6 million and $1.2 million, respectively.

F-26

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

20. Commitments and Contingencies

Indemnification Agreements

In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into and expects to enter into additional engagement letters orindemnification agreements with various consultants, advisors, professionalsmembers of its Board of Directors and others.certain of its executive officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their role, status or service as directors or officers. The servicesmaximum potential amount of future payments the Company could be required to make under these engagement lettersindemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not currently aware of any indemnification claims and agreements are materialhas not accrued any liabilities related to such obligations in its condensed consolidated financial statements as of March 31, 2022 or December 31, 2021.

Legal Proceedings

The Company is not a party to any litigation and does not have contingency reserves established for any litigation liabilities. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and in some instances include contingent or success fees. Contingent or success fees (but not deferred underwriting compensation) would be charged to operations inreasonably estimable under the quarter that an initial Business Combination is consummated. In most instances (except with respect to our independent registered public accounting firm), these engagement letters and agreements are expected to specifically provide that such counterparties waive their rights to seek repayment from the funds in the Trust Account.

Risks and Uncertainties – COVID-19

Management continues to evaluate the impactprovisions of the COVID-19 pandemic onauthoritative guidance that addresses accounting for contingencies. The Company expenses the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, resultscosts related to such legal proceedings as incurred.

F-27


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

TheYou should read the following discussion and analysis of the Company’sour financial condition and results of operations should be read in conjunctiontogether with theour condensed consolidated financial statements and therelated notes thereto containedincluded elsewhere in this report.

Special Note Regarding Forward-Looking Statements

AllQuarterly Report on Form 10-Q and our audited consolidated financial statements other than statements of historical factand related notes for the year ended December 31, 2021 included in this section and elsewhere in thisour Annual Report on Form 10-Q regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. When used in this Form 10-Q, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or the Company’s management, identify forward-looking statements. Such10-K. This discussion contains forward-looking statements are based on theupon current plans, expectations and beliefs of management, as well as assumptions made by,involving risks and information currently available to, the Company’s management. Actualuncertainties. Our actual results couldmay differ materially from those contemplated by theanticipated in these forward-looking statements as a result of certainvarious factors, detailed inincluding those set forth under “Risk Factors” section of our filings with the SEC.

Overview

We are a blank check company incorporatedAnnual Report on January 24, 2020 as a Delaware corporation and formedForm 10-K for the purposefiscal year ended December 31, 2021 and in other parts of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similarthis Quarterly Report on Form 10-Q.

On July 16, 2021, we consummated the business combination with one or more businesses (the “Initial Business Combination”). We intend to effectuate our Initial Business Combination using cash from the proceeds of our initial public offering that was completed in August 2020 (the “Public Offering”) and the sale of warrants in a private placement (the “Private Placement”) that occurred simultaneously with the completion of the Public Offering (the “Private Placement Warrants”“Merger”), our capital stock, debt or a combination of cash, stock and debt.

The issuance of additional shares of our stock in an Initial Business Combination:

may significantly dilutecontemplated by the equity interest of our stockholders;

may subordinate the rights of holders of our common stock if preferred stock is issued with rights senior to those afforded our common stock;

could cause a change in control if a substantial number of shares of our common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and

may adversely affect prevailing market prices for our Class A common stock and/or warrants.

Similarly, if we issue debt securities or incur other indebtedness to finance our Initial Business Combination, it could result in:

default and foreclosure on our assets if our operating revenues after an Initial Business Combination are insufficient to repay our debt obligations;

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

our inability to obtain necessary additional financing if the debt security or other indebtedness contains covenants restricting our ability to obtain such financing while the debt security or other indebtedness is outstanding;

our inability to pay dividends on our common stock;

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, or limit our ability to pay expenses, make capital expenditures and acquisitions and fund other general corporate purposes;


limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and
other disadvantages compared to our competitors who have less debt.

At March 31, 2021, we had approximately $579,000 in cash outside of the Trust Account. We expect to incur significant costs in the pursuit of an Initial Business Combination and we cannot assure you that our plans to complete an Initial Business Combination will be successful.

Recent Developments – COVID-19

The COVID-19 pandemic has resulted in a widespread health crisis that has adversely affected the economies and financial markets worldwide. The business of any potential target business with which we consummate a business combination could be materially and adversely affected. Furthermore, we may be unable to complete a business combination if continued concerns relating to COVID-19 restrict travel, limit the ability to have meetings with potential investors or the target company’s personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a timely manner. The extent to which COVID-19 impacts our ability to consummate a business combination will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global concern continue for an extended period of time, our ability to consummate a business combination, or the operations of a target business with which we ultimately consummate a business combination, may be materially adversely affected, however, the specific impact is not readily determinable as of the date of this report.

Recent Developments – Merger Agreement

On March 5, 2021, NewHold Investment Corp., (the “Company”), entered into an Agreement and Plan of Merger, (the “Merger Agreement”) by and among the Company,dated March 5, 2021, with NHIC Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), a Delaware corporation (“Evolv”as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, a business combination between the Company and Evolv will be effected through the merger of Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the merger as a wholly owned subsidiary of NHIC. Upon the Company (the “Merger”). The Board of Directorsclosing of the Company (the “Board”) has unanimously (i) approvedMerger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC.

As used in this Quarterly Report on Form 10-Q, unless otherwise indicated or the context otherwise requires, references to “we,” “us,” “our,” the “Company” and declared advisable“Evolv” refer to the Merger Agreement,consolidated operations of Evolv Technologies Holdings, Inc. and its subsidiaries. References to “NHIC” refer to the company prior to the consummation of the Merger and references to “Legacy Evolv” refer to Evolv Technologies, Inc. dba Evolv Technology, Inc. prior to the other transactions contemplated thereby and (ii) resolved to recommend approvalconsummation of the Merger AgreementMerger.

Business Overview

We are a global leader in AI-based weapons detection for security screening. Unlike conventional walk-through metal detectors, our products use advanced sensors, artificial intelligence software, and related matterscloud services to reliably detect guns, improvised explosives, and large knives while ignoring harmless items like phones and keys. This not only enhances security at venues and facilities but also improves the visitor experience by making screening up to ten times faster than alternatives at up to 70% lower total cost.

Our products have screened over 250 million visitors worldwide. We believe that we have screened more people through advanced systems than any organization other than the stockholdersUnited States Transportation Security Administration (“TSA”). Our customers include many iconic venues across a wide variety of industries including major sports teams, notable performing arts and entertainment venues, major tourist destinations and cultural attractions, large industrial workplaces, large school districts, and prominent houses of worship. We offer our products for purchase and primarily under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue and creates expansion and upsell opportunities.

Our mission is to make the world a safer and more enjoyable place to live, work, study, and play. We are focused on delivering value in the spaces in and around the physical threshold of large venues and facilities. We believe that digitally transforming the threshold experience is one of the Company.most exciting innovation opportunities of our time. We believe that our ongoing innovations will not only make venues and facilities safer and more enjoyable, but also more efficient and profitable.

Evolv is engaged in the business of providing artificial intelligence touchless security screening. Evolv is based in Waltham, Massachusetts.

More complete information about the Merger Agreement and related Support Agreement, Amended and Restated Insider Letter Agreement, form of Subscription Agreement and Stockholder Agreement are filed with the Current Report on Form 8-K filed on March 8, 2021.

Results of Operations and Known Trends or Future Events

For the period from January 24, 2020 (date of inception) to March 31, 2021Since our activities consisted of formation and preparation for the Public Offering and, subsequent to the Public Offering, identifying and completing a suitable Initial Business Combination. As such,inception, we had no operations orhave incurred significant operating expenses until August 2020.


losses. Our normal operating costs include costs associated withability to generate revenue and achieve cost improvements sufficient to achieve profitability will depend on the successful further development and commercialization of our searchproducts. We generated revenue of $8.7 million and $4.0 million for an Initial Business Combination, costs associated with our governance and public reporting and state franchise taxes expected to total approximately $17,000 per month (see below), a charge of $15,000 per month from our Sponsor for administrative services. Our costs in the three months ended

1

March 31, 2022 and 2021, also include the costsrespectively. We generated a net loss of our public reporting, governance$14.6 million and related costs, subsequent to the Public Offering as well as professional and consulting fees and travel associated with evaluating various Initial Business Combination candidates. Costs associated with our governance and public reporting have increased since the Public Offering and were approximately $85,000$13.8 million for the three months ended March 31, 2021. Costs2022 and 2021, respectively. We expect to continue to incur operating losses as we focus on growing and establishing recurring commercial sales of our products in both the United States and international markets, including growing our sales and marketing teams, scaling our manufacturing operations, and continuing research and development efforts to develop new products and further enhance our existing products.

Because of the numerous risks and uncertainties associated with professional,product development and commercialization, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve or maintain profitability. Until such time, if ever, as we can generate substantial revenue sufficient to achieve profitability, we expect to finance our operations through a combination of equity offerings and debt financings. In July 2021, we received gross proceeds of $300.0 million from our PIPE Investment as well as $84.9 million in proceeds, net of redemptions received from the closing of the Merger. However, we may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we are unable to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay, scale back or discontinue the further development and commercialization efforts of one or more of our products, or may be forced to reduce or terminate our operations. See “Liquidity and Capital Resources.”

Merger Agreement

NewHold Investment Corporation Merger

On July 16, 2021, we completed the previously announced Merger, pursuant to the Agreement and Plan of Merger, dated as of March 5, 2021, and amended by the First Amendment to Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 5, 2021. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. and the officers of NHIC, the legal predecessor company, resigned. The officers of Legacy Evolv became the officers of the Company, and the Company listed its shares of common stock, par value $0.0001 per share, on Nasdaq under the symbol “EVLV”.

Prior to the completion of the Merger, we entered into subscription agreements (collectively, the “PIPE Investment”) with certain parties subscribing for shares of our common stock (the “Subscribers”). Pursuant to the PIPE Investment, we issued 30,000,000 shares of common stock for a purchase price of $10.00 per share with gross proceeds of $300.0 million. The purpose of the PIPE Investment was to fund general corporate expenses.

Upon the closing of the Merger, each share of NHIC Class B common stock issued and outstanding immediately prior to the effective time of the Merger, which totaled 10,391,513 shares held by the NHIC Initial Shareholders (“Initial Shareholders”), was automatically converted into one validly-issued share of our common stock.

Additional information regarding the Merger Agreement appears in Note 3 of our condensed consolidated financial statements in Item 1. Part I of this Report.

COVID-19

We have taken, and will continue to take, actions to mitigate the impact of the COVID-19 pandemic on our cash flow and results of operations and financial condition. While we have experienced supply chain challenges during the three months ended March 31, 2022, we do see this being overcome in the near future. In the long-term, we believe that the COVID-19 pandemic may encourage organizations to continue to reassess their security screening processes and may continue to accelerate their adoption of solutions such as touchless security screening, which could create additional demand for our products.

Additional information regarding COVID-19 risks appear in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2021.

2

Key Factors Affecting Our Operating Results

We believe that our performance and future success depend on many factors that present significant opportunities for us but also pose risks and challenges, including the following:

Adoption of our Security Screening Products

We believe the world will continue to focus on the safety and security of people in the places where they gather. Many of these locations are moving toward a more frictionless security screening experience. We believe that we are well-positioned to take advantage of this opportunity due diligence and consulting fees related to our reviewproprietary technologies and global distribution capabilities. Our products are designed to empower venues and facilities to realize the full benefits of business combination candidates were approximately $1,155,000touchless security screening, including a rapid visitor throughput and minimal security staff to screened visitor physical contact. We expect that our results of operations, including revenue, will fluctuate for the foreseeable future as venues and facilities continue to shift away from conventional security screening processes towards touchless security screening. The degree to which potential and current customers recognize these benefits and invest in our products will affect our financial results.

Pricing, Product Cost and Margins

Revenue generated by the sale of products represented 60% and 63% of our total revenue for the three months ended March 31, 2021. As2022 and 2021, respectively. The remaining revenue was generated from subscription sales and services for our products. Going forward, we identify Initial Business Combination candidates, our costs are expected to increase significantly in connection with negotiating and executing a definitive agreement and related agreements as well as additional professional, due diligence and consulting fees and travel costs that will be required in connection with an Initial Business Combination. We expect our costs to increase significantly in connection with negotiating and executing a merger agreement and related agreements as well as additional professional, due diligence and consulting fees and travel costs that will be required in connection with an Initial Business Combination.

Since our operating costs are not expectedproducts to be deductible for federal income tax purposes, we are subject to federal income taxes on the income from the Trust Account less taxes. However, we are permitted to withdraw interest earned from the Trust Account for the payment of taxes.

Our Public Offering and Private Placement closed in August 2020 as more fully described in “Liquidity and Capital Resources” below. The proceeds in the Trust Account were initially investedadopted in a money market fund that invests solely in direct U.S. government obligations meeting the applicable conditionsvariety of Rule 2a-7 of the Investment Company Act of 1940. In August 2020, the money market fundvertical industry markets and geographic regions. Subscription revenue was largely liquidated$3.0 million and the trust assets were invested in U.S. government treasury bills which matured in February 2021 and were replaced with U.S. government treasury bills maturing in May 2021. The Company’s U.S. treasury bills yield approximately 0.1% on a yearly basis. Interest on the Trust Account was approximately $19,000$1.3 million for the three months ended March 31, 2021. At2022 and 2021, respectively. With the interest rate earned onfurther development, enhancement, and maintenance of Evolv Insights and its analytical platform during the current portfoliothree months ended December 31, 2021, we expect this source of subscription revenue to become a more significant portion of our total revenue in the trust account, it is unlikely that the income on the trust assets will be sufficientyear ended December 31, 2022, given its new features, functions and capabilities.

Pricing may also vary by region due to fund the tax and working capital payments that are permitted to be withdrawn from the trust.

As discussed further in Note 6 to the condensed financial statements, the Company accounts for its outstanding public and private warrants as components as derivative liabilities in the accompanying unaudited condensed financial statements.market-specific dynamics. As a result, our financial performance depends, in part, on the mix of sales/bookings/business in different markets during a given period. In addition, we are subject to price competition, and our ability to compete in key markets will depend on the success of our investments in new technologies and cost improvements as well as our ability to efficiently and reliably introduce cost-effective touchless security screening products` to our customers.

Continued Investment and Innovation

We believe that we are a global leader in AI-based weapons detection for security screening, offering transformative technologies that enable higher throughput, a more frictionless visitor experience, and substantial cost savings through our product innovations. Our performance is significantly dependent on the investment we make in our research and development efforts and on our ability to be at the forefront of the security screening industry. It is essential that we continually identify and respond to rapidly evolving customer requirements, develop and introduce innovative new products, enhance existing products and generate customer demand for our products. We believe that investment in our security screening products will contribute to long-term revenue growth, but it may adversely affect our near-term profitability.

Contingent Earn-out Shares

In connection with the Merger and pursuant to the Merger Agreement, certain of the Legacy Evolv shareholders and Legacy Evolv Service Providers are entitled to receive additional shares of the Company’s common stock (the “Earn-Out Shares”) upon the Company is required to measureachieving certain milestones.

The Earn-Out Shares are classified as liabilities in our condensed consolidated balance sheets and were initially measured at fair value. Each reporting period, the Earn-Out Shares are remeasured and changes in the fair value of the publiccontingent earn-out are recorded in other income (expense), net in our condensed consolidated statements of operations and private warrantscomprehensive loss. When the Triggering Events have been achieved and the Earn-Out Shares are issued, the

3

Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.

Additional information regarding Contingent Earn-out Shares vesting provisions and accounting treatment appear in Note 2 of our consolidated financial statements for the year ended December 31, 2021 of our Annual Report on Form 10-K.

Contingently Issuable Common Stock

Prior to the Merger, certain NHIC shareholders owned 4,312,500 Founder Shares. 1,897,500 shares vested at the endclosing of eachthe Merger, 517,500 shares were transferred back to NHIC and then contributed to Give Evolv LLC. The remaining 1,897,500 outstanding shares shall vest upon the Company achieving certain milestones.

The Founders Shares (the “Contingently Issuable Common Stock”) are classified as liabilities in our condensed consolidated balance sheets and were initially measured at fair value. Each reporting period, the Founders Shares are remeasured and recognize changes in the fair value of the contingently issuable common stock are recorded in other income (expense), net in our condensed consolidated statements of operations and comprehensive loss. When the Triggering Events have been achieved and the Founders Shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.

Additional information regarding Contingently Issuable Common Stock vesting provisions and accounting treatment appear in Note 2 of our consolidated financial statements for the year ended December 31, 2021 of our Annual Report on Form 10-K.

Components of Results of Operations

Revenue

We derive revenue from (1) subscription arrangements generally accounted for as operating leases, (2) from the priorsale of products, inclusive of SaaS and maintenance, and (3) professional services. Our arrangements are generally noncancelable and nonrefundable after ownership passes to the customer for product sales and upon installation for subscriptions. Revenue is recognized net of sales tax.

Product Revenue

We derive a portion of our revenue from the sale of our Express and Edge equipment and related add-on accessories to customers. Revenue is recognized when control of the product has transferred to the customer, which follows the terms of each contract. We expect product revenue to decline as a percentage of our overall revenue overtime as more and more customers enter full subscription transactions with us and as our subscription becomes more valuable to our business.

Subscription Revenue

In addition to selling our products directly to customers, we also lease our Express and Edge equipment which we classify as subscription revenue. Lease terms are typically four years and customers generally pay either a quarterly or annual fixed payment for the lease and maintenance elements over the contractual lease term. Equipment leases are generally classified as operating leases as they do not meet any of the sales-type lease criteria per ASC 842 and recognized ratably over the duration of the lease. There are no contingent lease payments as a part of these arrangements.

Generally, lease arrangements include both lease and non-lease components. The non-lease components relate to (1) distinct services, such as SaaS, maintenance installation and training, and (2) any add-on accessories. Installation and training are included in service revenue as described below, and add-on accessories are included in product revenue as described above. Because the equipment, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern the equipment lease and SaaS/maintenance performance

4

obligations are classified as a single category of subscription revenue in our condensed consolidated statements of operations and comprehensive loss.

Services Revenue

We provide SaaS, maintenance installation and training services for our products. Revenue for installation and training are recognized upon transfer of control of these services, which are normally rendered over a short duration. Maintenance consists of technical support, bug fixes and when-and-if available threat updates. SaaS and maintenance revenue is recognized ratably over the period of the arrangement. We sell separately priced extended or nonstandard warranty services and preventative maintenance plans, which are recognized ratably over the associated service period.

Cost of Revenue

We recognize cost of revenue in the same manner that the related revenue is recognized.

Cost of Product Revenue

Cost of product revenue consists primarily of costs paid to third party manufacturers, labor costs, shipping costs, amortization expense related to internal-use software, and stock-based compensation expense.

Cost of Subscription Revenue

Cost of subscription revenue consists primarily of labor costs, shipping costs, amortization expense related to internal-use software, depreciation expense related to leased units, and stock-based compensation expense.

Cost of Services Revenue

Cost of services revenue consists of costs related to SaaS and maintenance services. Costs of services revenue related to SaaS consists of costs of maintaining the Evolv cloud portal and our internal-use software, associated with our Evolv Express units. Cost of services revenue related to maintenance consists primarily of labor, spare parts, shipping costs, field service repair costs, equipment, supplies, and stock-based compensation expense.

A provision for the estimated cost related to warranty is recorded to cost of product, subscription, or services revenue at the time the associated revenue is recognized as necessary. Our estimate of costs to service the warranty obligations is based on historical experience and expectations of future conditions. As of March 31, 2022, the warranty accrual was less than $0.1 million.

Gross Profit and Gross Margin

Our gross profit is calculated based on the difference between our revenues and cost of revenues. Gross margin is the percentage obtained by dividing gross profit by our revenue. Our gross profit and gross margin are, or may be, influenced by a number of factors, including:

Market conditions that may impact our pricing;
Product mix changes between established products and new products;
Our cost structure for manufacturing operations, including contract manufacturers, relative to volume, and our product support obligations;
Our ability to maintain our costs on the components that go into the manufacture of our product; and
Write-offs of inventory.

We expect our gross margins to fluctuate over time, depending on the factors described above.

5

Research and Development

Our research and development expenses represent costs incurred to support activities that advance the development of innovative security screening technologies, new product platforms, as well as activities that enhance the capabilities of our existing product platforms. Our research and development expenses consist primarily of salaries and bonuses, employee benefits, stock-based compensation, prototypes, design expenses, consulting and contractor costs, and the impact of the capitalization of costs associated with developing the Evolv cloud portal, our internal-use software. We expect research and development costs will increase on an absolute dollar basis for the year ended December 31, 2022 compared to the year ended December 31, 2021 as we continue to invest in advancing our portfolio of security screening products.

Sales and Marketing

Sales and marketing expenses consist primarily of personnel-related expenses associated with our sales and marketing, customer success and global service, business development, and strategy functions, as well as costs related to trade shows and events, and stock-based compensation. We expect our sales and marketing costs will increase on an absolute dollar basis for the year ended December 31, 2022 compared to the year ended December 31, 2021 as we expand our headcount and initiate new marketing campaigns.

General and Administrative

General and administrative expenses consist primarily of personnel-related expenses associated with our executive, finance, investor relations, legal, information technology, and human resources functions, as well as professional fees for legal, audit, accounting and other consulting services, stock-based compensation, and sales tax contingencies. We expect our general and administrative expenses will increase on an absolute dollar basis for the year ended December 31, 2022 compared to the year ended December 31, 2021 as a result of operating as a public company, including expenses necessary to comply with the rules and regulations applicable to companies listed on a national securities exchange and related to compliance and reporting obligations pursuant to the rules and regulations of the SEC, as well as increased expenses for general and director and officer insurance, and other administrative and professional services. In addition, we expect to incur additional costs as we hire additional personnel and enhance our infrastructure to support the anticipated growth of the business.

Loss From Impairment of Property and Equipment

Impairment of property and equipment relates to Edge units and Express prototype units that were removed from service and retired. We are transitioning our domestic customers from the Edge units to our most current Express units, which also resulted in an impairment of the remaining economic value of such assets.

Interest Expense

Interest expense includes cash interest paid on our long-term debt and amortization of deferred financing fees and costs.

Interest Income

Interest income relates to interest earned on our lease receivables for our Evolv Express units.

Change in Fair Value of Derivative Liability

In August through September 2019 and in September 2020, we issued Convertible Notes to several investors (the “2020 Convertible Notes”) that provided a conversion option whereby upon the closing of a specified financing event the notes would automatically convert into shares of the same class and series of our capital stock issued to other investors in the financing at a conversion price equal to 85% and 80%, respectively, of the price per share of the securities paid by the other investors. This conversion option was determined to be an embedded derivative that was required to be bifurcated and accounted for separately from the notes. The derivative liability was initially recorded at fair value upon issuance of

6

the notes and is subsequently remeasured to fair value at each reporting date. Changes in the fair value of the derivative liability are recognized in the condensed consolidated statements of operations and comprehensive loss. In October 2019, the specified financing event was consummated, as such the 2020 Convertible Notes issued August through September 2019 were converted into shares of Series B-1 Preferred Stock and the derivative liability was extinguished.

In January and February 2021, we entered into a Convertible Note Purchase Agreement (the “2021 Convertible Notes”) with various investors for gross proceeds of $30.0 million with a stated interest rate of 8.0% per annum. The 2021 Convertible Notes provided a conversion option whereby upon the closing of a Qualified Financing event, in which the aggregate gross proceeds totaled at least $100.0 million, the 2021 Convertible Notes would automatically convert into shares of the same class and series of capital stock of the Company issued to other investors in the financing at a conversion price equal to 80% of the price per share paid by the other investors. The conversion option met the definition of an embedded derivative and was required to be bifurcated and accounted for separately from the notes. The proceeds from the 2021 Convertible Notes were allocated between the derivative liability and included in long-term liabilities on the Company��s condensed consolidated balance sheet. The difference between the initial carrying value of the notes and the stated value of the notes represented a discount that was accreted to interest expense over the term of the Convertible Notes using the effective interest method.

In June 2021, we modified the 2021 Convertible Notes to grant the holders an additional 1,000,000 shares of NHIC common stock as further consideration upon the automatic conversion of the notes upon closing of the Merger. The modification of the 2021 Convertible Notes resulted in the recognition of a derivative liability for the fair value of the 1,000,000 NHIC shares as of June 21, 2021 as well as a bifurcated embedded derivative for conversion feature into shares of the same class and series of capital stock of the Company issued to other investors in the financing at a conversion price equal to 80% of the price per share paid by the other investors.

Upon the closing of the Merger, the Convertible Notes automatically converted into 4,408,672 shares of the Company’s common stock and the holders of the 2021 Convertible Notes also received 1,000,000 shares of the Company’s common stock, as noted above. Upon the conversion of the Convertible Notes, the carrying value of the debt of $32.8 million, and the related derivative liability of $19.7 million and accrued interest of $0.2 million were derecognized resulting in a loss on extinguishment of debt of $0.9 million recorded in other income (expense), net in the condensed consolidated statements of operations and comprehensive loss.

Change in Fair Value of Contingent Earn-out Liability

In connection with the Merger and pursuant to the Merger Agreement, certain of Legacy Evolv’s initial shareholders are entitled to receive additional shares of our common stock upon us achieving certain milestones. The earn-out arrangement with the Legacy Evolv shareholders is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations and comprehensive loss.

Change in Fair Value of Contingently Issuable Common Stock Liability

Prior to the Merger, certain NHIC shareholders owned 4,312,500 shares of Founder Shares. 1,897,500 shares vested at the closing of the Merger, 1,897,500 shares shall vest upon us achieving certain milestones and 517,500 shares were contributed to Give Evolv LLC. Those 1,897,500 outstanding contingently issuable common shares are accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations and comprehensive loss.

Change in Fair Value of Public Warrant Liability

In connection with the closing of the Merger, the Company assumed a warrant to purchase shares of common stock (the “Public Warrants”). We assessed the features of these warrants and determined that they qualify for classification as a liability. Accordingly, we recorded the warrants at fair value upon the closing of the Merger with the offset to additional paid-in capital.

7

Change in Fair Value of Common Stock Warrant Liability

We classify certain warrants for the purchase of shares of our common stock as a liability on our condensed consolidated balance sheets as these warrants are freestanding financial instruments that may require us to adjust the exercise price and number of shares that is not consistent with a fixed-for-fixed option pricing model. The warrant liability is initially recorded at fair value on the issuance date of each warrant and is subsequently remeasured to fair value at each reporting date. Changes in the fair value of the common stock warrant liability are recognized as a component of other income (expense), net in the condensed consolidated statements of operations and comprehensive loss. Changes in fair value of the common stock warrant liability will continue to be recognized until the warrants are exercised, expire or qualify for equity classification. In connection with the closing of the Merger, all common stock warrants that were issued prior to the closing of the Merger were converted into shares of the Company’s common stock.

Income Taxes

Our income tax provision consists of an estimate for U.S. federal and state income taxes based on enacted rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities and changes in tax law. There is no provision for income taxes for the three months ended March 31, 2022 and 2021 because we have historically incurred net operating results for each current period. losses and maintain a full valuation allowance against its deferred tax assets.

8

Results of Operations

Comparison of the Three Months Ended March 31, 2022 and 2021

The statementfollowing table summarizes our results of operations for the three months ended March 31, 2022 and 2021 reflects(in thousands):

Three Months Ended March 31, 

 

2022

2021

$ Change

 

% Change

Revenue:

  

Product revenue

$

5,194

$

2,502

$

2,692

108

%

Subscription revenue

 

3,020

 

1,300

 

1,720

132

Service revenue

 

501

 

197

 

304

154

Total revenue

 

8,715

 

3,999

 

4,716

118

Cost of revenue:

 

  

 

  

 

Cost of product revenue

 

5,576

 

2,229

 

3,347

150

Cost of subscription revenue

 

1,065

 

595

 

470

79

Cost of service revenue

 

448

 

127

 

321

253

Total cost of revenue

 

7,089

 

2,951

 

4,138

140

Gross profit

 

1,626

 

1,048

 

578

55

Operating expenses:

 

  

 

  

 

Research and development

 

4,286

 

3,612

 

674

19

Sales and marketing

 

12,053

 

3,684

 

8,369

227

General and administrative

11,093

2,899

8,194

283

Loss from impairment of property and equipment

 

96

 

 

96

*

Total operating expenses

 

27,528

 

10,195

 

17,333

170

Loss from operations

 

(25,902)

 

(9,147)

 

(16,755)

183

Other income (expense), net:

 

  

 

  

 

Interest expense

 

(142)

 

(2,447)

 

2,305

(94)

Interest income

209

209

*

Change in fair value of derivative liability

-

(1,425)

1,425

*

Change in fair value of contingent earn-out liability

 

4,226

 

 

4,226

*

Change in fair value of contingently issuable common stock liability

 

1,472

 

 

1,472

*

Change in fair value of public warrant liability

5,586

5,586

*

Change in fair value of common stock warrant liability

-

(736)

736

*

Total other income (expense), net

 

11,351

 

(4,608)

 

15,959

(346)

Net loss

$

(14,551)

$

(13,755)

$

(796)

6

%

* – Not meaningful

9

Revenue, Cost of Revenue and Gross Profit

Product Revenue

Three Months Ended March 31, 

 

2022

2021

$ Change

 

% Change

Product revenue

$

5,194

$

2,502

$

2,692

108

%

Cost of product revenue

$

5,576

$

2,229

$

3,347

150

%

Gross profit - Product revenue

$

(382)

$

273

$

(655)

(240)

%

Gross profit margin - Product revenue

 

(7)

%

 

11

%

N/A

(18)

%

The increase in product revenue and increase in cost of product revenue are primarily due to the increases in product sales of Evolv Express units, which included the significant increase in the adoption of Evolv Express units by schools, hotels and casinos, and professional sports arenas. The decreases in gross profit and gross profit margin are primarily driven by purchase price variances recorded on raw materials and the costs associated with the write-off of scrap inventory incurred without corresponding revenue. We expect to see improvement in our gross margins as we continue to engineer our product with lower cost components. As we continue to gain leverage in the marketplace with increased sales, we expect higher discounts from suppliers. We also expect to see improvements in gross margin to the extent shipping costs and high demand costs decline when global supply chain disruptions ease.

Subscription Revenue

Three Months Ended March 31, 

 

2022

2021

$ Change

 

% Change

Subscription revenue

$

3,020

$

1,300

$

1,720

132

%

Cost of subscription revenue

$

1,065

$

595

$

470

79

%

Gross profit - Subscription revenue

$

1,955

$

705

$

1,250

177

%

Gross profit margin - Subscription revenue

 

65

%

 

54

%

N/A

11

%

The increase in subscription revenue and increase in cost of subscription revenue are primarily due to a higher number of active Evolv Express units installed during the period, growth in our customer base and contribution from our channel partners. The increase in gross profit is primarily driven by our increased subscription revenue. The increase in gross profit margin was primarily driven by increased recurring revenue from increased active subscriptions and customer growth, which we expect to continue.

Service Revenue

Three Months Ended March 31, 

 

2022

2021

$ Change

 

% Change

Service revenue

$

501

$

197

$

304

154

%

Cost of service revenue

$

448

$

127

$

321

253

%

Gross profit - Service revenue

$

53

$

70

$

(17)

(24)

%

Gross profit margin - Service revenue

 

11

%

 

36

%

N/A

(25)

%

The increase in service revenue is primarily due to the increased number of purchase subscription units deployed in the preceding twelve months and increased installation and training related to the Evolv Express units. The decrease in gross profit is due the increase in field services costs associated with the Evolv Express units.

10

Research and Development Expenses

Three Months Ended March 31, 

 

2022

2021

$ Change

 

% Change

Personnel related (including stock-based compensation)

$

3,220

$

990

$

2,230

225

%

Materials and prototypes

388

2,284

(1,896)

(83)

Professional fees

562

260

302

116

Facilities related and other

 

116

78

 

38

49

Total research and development expenses

$

4,286

$

3,612

$

674

19

%

The increase in personnel related expenses is due to an increase in additional personnel costs resulting from new hires in our research and development function during the second half of 2021 and the first three months in 2022, an increase in bonuses, an increase in stock-based compensation and an increase in recruiting costs, partially offset by of $0.3 million of wages capitalized in association with the development of internal-use software. The decrease in materials and prototype costs is due to the transition from prototype production to standard manufacturing of the Evolv Express, which results in lower prototyping costs. The increase in professional fees is due to an increase in consulting related to research and development efforts for Evolv Express units. The capitalization of the development of internal-use software is due to internal and external costs associated with further developing the Evolv cloud portal associated with our Evolv Express units.

Sales and Marketing Expenses

Three Months Ended March 31, 

 

2022

2021

$ Change

 

% Change

Personnel related (including stock-based compensation)

$

8,379

$

2,767

$

5,612

203

%

Direct marketing and customer field services

2,082

401

1,681

419

Travel and entertainment

686

151

535

354

Professional fees

272

186

86

46

Facilities related and other

 

634

179

 

455

254

Total sales and marketing expenses

$

12,053

$

3,684

$

8,369

227

%

The increase in personnel related expenses is due to an increase in additional personnel costs resulting from new hires in our sales and marketing functions, which includes functions such as partner development, customer success, technical sales and support, and other business development, during the second half of 2021 and the first three months in 2022, an increase in bonuses and commissions, and an increase in stock-based compensation. The increase in direct marketing and customer field services is due to an increase in trade shows and events and an increase in sales volume. The increase in travel and entertainment expense is due to an increase in travel costs for in-person sales personnel meetings and events. The increase in professional fees is due to an increase in consulting fees related to business development and marketing as part of efforts to drive sales growth. The increase in facilities related and other expenses is primarily due to an increase in subscriptions related to gathering market research.

11

General and Administrative Expenses

Three Months Ended March 31, 

 

2022

2021

$ Change

 

% Change

Personnel related (including stock-based compensation)

$

4,235

$

574

$

3,661

638

%

Professional fees

3,314

2,004

1,310

65

Director and officer insurance

1,427

92

1,335

1,451

Non-income taxes

776

776

*

Facilities related and other

 

1,341

229

 

1,112

486

Total general and administrative expenses

$

11,093

$

2,899

$

8,194

283

%

* – Not meaningful

The increase in personnel related expenses is due to an increase in salaries and related costs resulting from expanding our administrative team, an increase in stock-based compensation, and severance. The increase in professional fees is due to an increase in accounting, audit, tax, and legal services provided to the Company to support public company requirements. The increase in director and officer insurance expense is due to us operating as a public company. The increase in non-income taxes is due to an increase in property taxes as well as an increase in our sales tax contingency liability as we may owe additional sales and use taxes in various jurisdictions. The increase in facilities related and other expenses is due to us relocating to our new corporate headquarters with a larger office space to accommodate our growth and a $0.4 million one-time payment to a former employee.

Loss From Impairment of Property and Equipment

Loss from impairment of property and equipment was $0.1 million for the three months ended March 31, 2022. There was no impairment for the three months ended March 31, 2021. This related to Edge units and Express prototype units that were removed from service and retired. We are transitioning our domestic customers from the Edge units to our most current Express units, which also resulted in an impairment of the remaining economic value of such assets.

Interest Expense

Interest expense was $0.1 million for the three months ended March 31, 2022, compared to $2.4 million for the three months ended March 31, 2021. The decrease of $2.3 million was primarily due to the Convertible Notes and corresponding accrued interest being converted into the Company’s common stock upon closing of the Merger.

Interest Income

Interest income was $0.2 million for the three months ended March 31, 2022. There was no interest income for the three months ended March 31, 2021. This related to the interest earned our lease receivables for our Evolv Express units.

Change in Fair Value of Derivative Liability

Change in fair value of the derivative liability was $0 for the three months ended March 31, 2022, compared to $1.4 million for the three months ended March 31, 2021. The change in fair value of the warrantderivative liability of approximately $2,646,000.

Liquidity and Capital Resources

In August 2020, we consummatedwas due to mark to market fluctuations prior to the Public Offering of an aggregate of 17,250,000 Units (including the full exerciseconversion of the underwriters’ overallotment option) at a price of $10.00 per unit generating gross proceeds of approximately $172,500,000 before underwriting discounts and expenses. Simultaneously withConvertible Notes upon the consummationclosing of the Public Offering, we consummated the Private PlacementMerger.

Change in Fair Value of 5,700,000 Private Placement Warrants, each exercisable to purchase one share of our Class A common stock at $11.50 per share, to the Sponsor and the Anchor Investor, at a price of $1.00 per Private Placement Warrant, generating gross proceeds, before expenses, of approximately $5,700,000.Contingent Earn-out Liability

The net proceeds from the Public Offering and Private Placement was approximately $174,256,000, netChange in fair value of the non-deferred portion ofcontingent earn-out liability was $4.2 million for the underwriting commissions of $3,450,000 and offering costs and other expenses of approximately $494,000. $172,500,000 of the proceeds of the Public Offering and the Private Placement have been deposited in the Trust Account and are not available to us for operations (except for withdrawal of interest amounts, if available, to pay taxes and $250,000 per year in working capital). Atthree months ended March 31, 2021, we had approximately $579,000 of cash available outside of2022, compared to $0 for the Trust Accountthree months ended March 31, 2021. This was due to fund our activities until we consummate an Initial Business Combination. In addition, we are permitted to withdraw cash from interest earned onestablishing the trust account for payment of taxes and for up to $250,000 of working capital.

Until the consummation of the Public Offering, the Company’s only sources of liquidity were an initial purchase of shares of our common stock for approximately $30,000 by the Sponsor and the Anchor Investor, and a total of $47,000 loaned by the Sponsor against the issuance of an unsecured promissory note (the “Note”). The Note was non-interest bearing and was paid in full on August 2020contingent earn-out liability in connection with the closing of the Merger. The change in fair value of the contingent earn-out liability from

12

issuance through period end is due to mark to market fluctuations driven by a decrease in stock price, resulting in income recognized in other income (expense), net in our condensed consolidated statements of operations and comprehensive loss.

Change in Fair Value of Contingently Issuable Common Stock Liability

Change in fair value of the contingently issuable common stock liability was $1.5 million for the three months ended March 31, 2022, compared to $0 for the three months ended March 31, 2021. This was due to establishing the contingently issuable common stock liability in connection with the closing of the Merger. The change in fair value of the contingently issuable common stock liability from issuance through period end is due to mark to market fluctuations driven by a decrease in stock price, resulting in income recognized in other income (expense), net in our condensed consolidated statements of operations and comprehensive loss.

Change in Fair Value of Public Offering.Warrant Liability

Change in fair value of the public warrant liability was $5.6 million for the three months ended March 31, 2022, compared to $0 for the three months ended March 31, 2021. This was due to establishing the public warrant liability in connection with the closing of the Merger. The change in fair value of the public warrant liability from issuance through period end is due to mark to market fluctuations driven by a decrease in the publicly traded warrant price, resulting in income recognized in other income (expense), net in our condensed consolidated statements of operations and comprehensive loss.

ForChange in Fair Value of Common Stock Warrant Liability

Change in fair value of the common stock warrant liability was $0 for the three months ended March 31, 2022, compared to $0.7 million for the three months ended March 31, 2021. The change in fair value of the common stock warrant liability was due mark to market fluctuations prior to the conversion of the common stock warrant liability upon the closing of the Merger.

Income Taxes

There is no provision for income taxes for the three months ended March 31, 2022 and 2021 because we have historically incurred net operating losses and maintain a full valuation allowance against our deferred tax assets. We have provided a valuation allowance for all of our deferred tax assets as a result of our historical net losses in the jurisdictions in which we operate. We continue to assess all positive and negative evidence, including our future taxable income by jurisdiction based on our recent historical operating results, the expected timing of reversal of temporary differences, various tax planning strategies that we may be able to enact in future periods, the impact of potential operating changes on our business and our forecasted results from operations in future periods based on available information at the end of each reporting period. To the extent that we are able to reach the conclusion that deferred tax assets are realizable based on any combination of the above factors in any given tax jurisdiction, a reversal of all or some related portion of our existing valuation allowances may occur.

Liquidity and Capital Resources

Our primary requirements for liquidity and capital are working capital, inventory management, capital expenditures and general corporate needs. We expect these needs to continue as we develop and grow our business. Prior to the Merger, as an early-stage company, we primarily obtained cash to fund our operations through preferred stock offerings and debt instruments. As of March 31, 2022, we had $270.9 million in cash and cash equivalents. We incurred a net loss of $14.6 million and $13.8 million for the three months ended March 31, 2022 and 2021, respectively. We incurred cash outflows from operating activities of $35.9 million and $12.0 million during the three months ended March 31, 2022 and 2021, respectively.

We expect our cash and cash equivalents, together with cash we expect to generate from future operations, will be sufficient to fund our operating expenses and capital expenditure requirements for a period of at least twelve months from the date of this Quarterly Report on Form 10-Q. However, because we are in the growth stage of our business and operate in an emerging field of technology, we expect to continue to invest in research and development and expand our

13

sales and marketing teams worldwide. We are likely to require additional capital to respond to technological advancements, competitive dynamics or technologies, customer demands, business opportunities, challenges, acquisitions or unforeseen circumstances and in either the short-term or long-term may determine to engage in equity or debt financings or enter into credit facilities for other reasons. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to continue to grow or support our business and to respond to business challenges could be significantly limited. In particular, the widespread COVID-19 pandemic, including variants, has resulted in, and may continue to result in, significant disruption of global financial markets, reducing our ability to access capital. If we are unable to raise additional funds when or on the terms desired, our business, financial condition and results of operations could be adversely affected.

PIPE Investment and Proceeds from the closing of the Merger

In July 2021, we received gross proceeds of $300.0 million from our PIPE Investment, as well as $84.9 million in proceeds, net of redemptions received in connection with the closing of the Merger.

Financing Arrangements

In December 2020, we entered into a $10.0 million credit agreement with JPMorgan Chase Bank, N.A. (“JPM Credit Agreement”) with a maturity date of December 3, 2024, and a revolving line of credit of up to $10.0 million with a maturity date of December 3, 2022, which extinguished the 2020 Silicon Valley Bank Term Loan. Under the terms of the JPM Credit Agreement, we received proceeds of $10.0 million. As of March 31, 2022, we had $9.9 million of debt outstanding. In September and December of 2020, we issued a total of $4.0 million of convertible notes (the “2020 Convertible Notes”). In January and February 2021, we issued a total of $30.0 million of convertible notes with a maturity date of September 2021.

Upon the closing of the Merger, the Convertible Notes automatically converted into 4,408,672 shares of the Company’s common stock and the holders of the 2021 Convertible Notes also received the right to receive 1,000,000 shares of the Company’s common stock, as noted above. Upon the conversion of the Convertible Notes, the carrying value of the debt of $32.8 million and the related derivative liability of $19.7 million and accrued interest of $0.2 million were derecognized resulting in a loss on extinguishment of debt of $0.9 million recorded in other income (expense), net, which was recorded during the three and nine months ended September 30, 2021.

Material Cash Requirements for Known Contractual and Other Obligations

The following is a description of commitments for capital expenditures and other known and reasonably likely cash requirements as of March 31, 2022. We anticipate fulfilling such commitments with our existing cash and cash equivalents obtained through operations, proceeds from long-term debt, closing of the Merger, and issuance of common stock in connection with the PIPE investment. Cash and cash equivalents amounted to $270.9 million as of March 31, 2022.

We entered into a new lease agreement for additional office space starting May 1, 2021 through October 31, 2024, with the option to extend through October 31, 2027 with written notice. We are required to maintain a minimum cash balance of $0.7 million as a security deposit on the leased space which is classified as restricted cash, current and restricted cash, non-current on the condensed consolidated balance sheet as of March 31, 2022. Total future minimum lease payments under this noncancelable operating lease amount to $3.0 million. See Note 6 to our condensed consolidated financial statements for the three months ended March 31, 2022.

14

Cash Flows

The following table sets forth a summary of cash flows for the periods presented:

    

Three Months Ended

March 31, 

2022

2021

Net cash used in operating activities

$

(35,867)

$

(12,038)

Net cash used in investing activities

 

(969)

 

(2,522)

Net cash provided by financing activities

 

216

 

31,978

Net increase (decrease) in cash, cash equivalents and restricted cash

$

(36,620)

$

17,418

Operating Activities

    

Three Months Ended

March 31, 

2022

2021

Net loss

$

(14,551)

$

(13,755)

Noncash (income) expense

 

(4,845)

 

5,976

Changes in operating assets and liabilities

 

(16,471)

 

(4,259)

Net cash used in operating activities

$

(35,867)

$

(12,038)

Net loss increased from $13.8 million for the three months ended March 31, 2021 to $14.6 million for the three months ended March 31, 2022 as a result of the factors discussed in the “Results of Operations” above.

Noncash income for the three months ended March 31, 2022 was primarily driven by $11.3 million of positive fair value adjustments to financial liabilities, partially offset by $5.2 million of stock-based compensation expense and $1.0 million of depreciation and amortization expense. Noncash expenses for the three months ended March 31, 2021 were primarily driven by $2.2 million of negative fair value adjustments to financial liabilities, $2.3 million of noncash interest expense primarily related to the accretion of the debt discount associated with the 2021 Convertible Notes and $1.1 million of stock-based compensation expense.

The $16.5 million change in operating assets and liabilities for the three months ended March 31, 2022 are primarily related to the following:

$7.0 million increase in inventory primarily due to increased production of units to meet customer demand;
$5.3 million increase in prepaid expenses and other current assets primarily due to an increase in prepaid deposits related to orders placed for Express units;
$2.1 million increase in accounts receivable primarily due to higher sales driven by an increase in customers and the timing of billings to customers;
$2.1 million decrease in accrued expenses and other current liabilities primarily due to the payment of 2021 compensation, bonuses and commissions paid during the three months ended March 31, 2022;
$1.9 million decrease in accounts payable due to the timing of invoicing and payments to vendors;
$0.5 million decrease in deferred rent due to the write-off of our deferred rent balances upon the adoption of the new lease standard;
$0.4 million increase in commission assets primarily due to a continued shift towards a subscription-based model;
$0.2 million decrease in operating lease liabilities due to the payments made on our operating lease, partially offset by
$2.8 million increase in deferred revenue primarily due to an increase in billings associated with higher sales.

15

The $4.3 million change in operating assets and liabilities for the three months ended March 31, 2021 are primarily related to the following:

$4.1 million increase in prepaid expenses and other current assets primarily due to prepaid subscriptions and insurance;
$1.0 million increase in commission assets and deferred revenue primarily due to a continued shift towards a subscription-based model;
$0.9 million increase in accounts receivable primarily due to higher sales driven by an increase in customers and the timing of billings to customers;  
$0.4 million increase in inventory primarily due to lower shipments to customers in the first quarter of the year compared to the fourth quarter of the year and due to an increase in the production of Express units to meet customer demand, partially offset by
$2.3 million increase in accrued expenses and other current liabilities and accounts payable primarily due to an increase in research and development and general and administrative expenses due to the growth in our business, the anticipation of the closing of the Merger, and the timing of vendor invoicing and payments.

Investing Activities

During the three months ended March 31, 2022, cash used in investing activities was $1.0 million, consisting of $0.3 million for the purchases of property and equipment and $0.6 million for the development of internal-use software.

During the three months ended March 31, 2021, cash used in operatinginvesting activities was approximately $749,000. Net loss of approximately $4,082,000 was affected by other expense for the change in the fair value$2.5 million, consisting of the warrant liabilitypurchases of $2,646,000 as well as income earned on investments held in the Trust Account of approximately $19,000. Changes in operating assetsproperty and liabilities provided approximately $706,000 of cash for operating activities.equipment.


The Company believes that it has sufficient working capital available to it at March 31, 2021 to fund its operations for at least the next twelve months.Financing Activities

The Company has until August 4, 2022 to complete an Initial Business Combination. If the Company does not complete an Initial Business Combination by August 4, 2022, the Company will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares for a per share price equal to a pro rata portion of the Trust Account, including interest, but less taxes payable (and less up to $100,000 of interest to pay dissolution expenses) and (iii) as promptly as reasonably possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining stockholders, as part of its plan of dissolution and liquidation. The initial stockholders have waived their redemption rights with respect to their founder shares; however, if the initial stockholders or any of their affiliates acquire shares of Class A common stock in or after the Public Offering, they will be entitled to a pro rata share of the Trust Account upon the Company’s redemption or liquidation in the event the Company does not complete an Initial Business Combination within the required time period.

In the event of such liquidation, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the price per unit in the Public Offering. At the interest rate earned on the current portfolio in the trust account, it is unlikely that the income on the trust assets will be sufficient to fund the tax and working capital payments that are permitted from the trust.

Off-balance sheet financing arrangements

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements.

We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or entered into any agreements for non-financial assets.

Contractual obligations

At March 31, 2021, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. In connection with the Public Offering, we entered into an Administrative Support Agreement with an affiliate of our Sponsor, pursuant to which the Company pays that affiliate $15,000 per month for office space, utilities and secretarial and administrative support.

Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying or accruing these monthly fees.

In connection with identifying an Initial Business Combination candidate, the Company expects to enter into engagement letters or agreements with various consultants, advisors, professionals and others in connection with an Initial Business Combination. The services under these engagement letters and agreements are likely to be material in amount and in some instances include contingent or success fees. Contingent or success fees (but not deferred underwriting compensation) would be charged to operations in the quarter that an Initial Business Combination is consummated. In most instances (except with respect to our independent registered public accounting firm), these engagement letters and agreements are expected to specifically provide that such counterparties waive their rights to seek repayment from the funds in the Trust Account.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. The Company has identified the following as its critical accounting policies:

18

Emerging Growth Company

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accounting standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Deferred Offering Costs:

The Company complies with the requirements of the FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (SAB) Topic 5A — “Expenses of Offering”. Costs incurred in connection with preparation for the Offering were approximately $9,981,000 including underwriters’ discount paid and deferred of $9,488,000. Such costs were allocated among the equity and warrant liability components based on the relative fair value of the warrants and approximately $9,596,000 has been charged to equity for the equity components and approximately $390,000 has been charged to other expense for the warrant liability components upon completion of the Public Offering.

Redeemable Common Stock:

As discussed in Note 3, all of the 17,250,000 public shares sold as part of Units in the Public Offering contain a redemption feature which allows for the redemption of public shares if the Company holds a stockholder vote or there is a tender offer for shares in connection with a Business Combination. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company did not specify a maximum redemption threshold, its charter provides that in no event will it redeem its public shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001 upon the closing of a Business Combination.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the securities at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by adjustments to additional paid-in capital. Accordingly, at March 31, 2021 and December 31 2020, 13,669,161 and 14,077,350 shares, respectively, of the 17,250,000 public shares were classified outside of permanent equity.

Net Income (Loss) per Share

Net income (loss) per common share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding for the period. The Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase an aggregate of 14,325,000 shares of Class A common stock in the calculation of diluted income (loss) per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted income (loss) per common share is the same as basic loss per common share for the period.


The Company’s statement of operations includes a presentation of income (loss) per share for common stock subject to redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss) per share, basic and diluted for Class A common stock is calculated by dividing the interest income earned on the funds in the Trust Account, net of income tax expense and franchise tax expense, by the weighted average number of shares of Class A common stock outstanding since their original issuance. Net income (loss) per common share, basic and diluted, for shares of Class B common stock is calculated by dividing the net income (loss), less income attributable to Class A common stock, by the weighted average number of shares of Class B common stock outstanding for the period. Net income (loss) available to each class of common stockholders is as follows forDuring the three months ended March 31, 2021 and for2022, cash provided by financing activities was $0.2 million,  consisting of $0.2 million from the period from January 24, 2020 (dateexercise of inception) to March 31, 2021:stock options.

  Three months
Ended March 31,
  For the Period From
January 24,
2020
(date of inception) to
March 31,
 
  2021  2020 
Net income available to Class A common stockholders:      
Interest income $19,000  $- 
Less: Income and franchise taxes  (19,000)  - 
Net income attributable to Class A common stockholders $-  $- 
         
Net income available to Class B common stockholders:        
Net loss $(4,082,000) $(2,000)
Less: amount attributable to Class A common stockholders  -   - 
Net (loss) attributable to Class B common stockholders $(4,082,000) $(2,000)

Income Taxes:

The Company follows the asset and liability method of accounting for income taxes under FASB ASC, 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

The Company’s currently taxable income consists of interest income on the Trust Account net of taxes. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three months ended March 31, 2021, andcash provided by financing activities was $32.0 million, consisting of $31.9 million from the period from January 24, 2020 (dateissuance of inception) to March 31, 2020, the Company recorded income tax expense of approximately $-0- in both periods, respectively, related to interest income earned on the Trust Accountlong-term debt, net of taxes. The Company’s effective tax rateissuance costs, and $0.5 million from the exercise of stock options, partially offset by $0.4 million in net cash out flows for the repayment of our finance obligations.

Recent Accounting Pronouncements

A description of recently issued accounting pronouncements that may potentially impact our financial position, results of operations or cash flows is disclosed in Note 2 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Critical Accounting Policies and Estimates

Our critical accounting policies and estimates are described in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition” for the year ended December 31, 2021 in our Annual Report on Form 10-K. There have been no material changes to our critical accounting policies and estimates during the three months ended March 31, 20212022 outside of our critical accounting policies and estimates described below.

Leases

We lease our corporate headquarters under a non-cancelable operating lease that expires in October 2024. We determine if our arrangement contains a lease at inception. We do not separate lease and non-lease components of our arrangement determined to contain a lease.

16

We use our estimated incremental borrowing rate, which is derived from information available at the period from January 24, 2020 (datelease commencement date, in determining the present value of inception)operating lease payments. To determine the estimated incremental borrowing rate, we use publicly available credit ratings for peer companies and estimate the incremental borrowing rate using yields for maturities that are in line with the duration of the lease payments.

To determine the residual value estimates and useful life of equipment that we lease to March 31, 2020 was approximately -0 -% in both periods which differs from the expected income tax rate dueour customers, we are required to make judgments about future events that are subject to risks and uncertainties outside of their control, such as inventory levels of new equipment, changing consumer preferences, new technology and mandatory regulations. We have disciplines related to the start-up costs (discussed above) which are not currently deductible,management and maintenance of our leased equipment designed to manage the risk associated with the residual values of our revenue generating equipment. We periodically review and adjust, as well as business combinationappropriate, the estimated residual values and warrant liability costs or credits which may not be deductible and the low leveluseful lives of interest income. At March 31, 2021 and December 31, 2020, the Company has a deferred tax asset of approximately $550,000 and $200,000, respectively, primarily related to start-up and Business Combination costs. Management has determined that a full valuation allowance of the deferred tax asset is appropriate at this time.

FASB ASC 740 prescribes a recognition threshold and a measurement attributeexisting revenue generating equipment for the financial statement recognitionpurposes of recording depreciation expense. Based on the results of our analysis, we may adjust the estimated residual values and measurementuseful lives of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits asindividual assets of March 31, 2021. Theour revenue generating equipment each year.

Emerging Growth Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at March 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Warrant Liability

Status

The Company accounts for warrantsJumpstart Our Business Startups Act of 2012, or the JOBS Act, permits an “emerging growth company” such as either equity-classifiedus to take advantage of an extended transition period to comply with new or liability-classified instruments based on an assessment of the warrant’s specific terms andrevised accounting standards applicable authoritative guidance FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480,public companies until those standards would otherwise apply to private companies. We meet the definition of a liability pursuantan “emerging growth company” and have elected to ASC 480,use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and whetherprivate companies until the warrants meet allearlier of the requirements for equity classification under ASC 815, including whetherdate we (1) are no longer an emerging growth company or (2) affirmatively and irrevocably opt out of the warrants are indexedextended transition period provided in the JOBS Act. As a result of this election, we will not be subject to the Company’s own shares, amongsame new or revised accounting standards as other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuancepublic companies that are not emerging growth companies and our condensed consolidated financial statements may not be comparable to other public companies that comply with new or revised accounting pronouncements as of each subsequent quarterly period end date whilepublic company effective dates. We may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private companies.

We will remain an emerging growth company until the warrants are outstanding.


For issued or modified warrants that meet allearlier of (1) the last day of the criteria for equity classification,fiscal year (a) following the warrantsfifth anniversary of the completion of the initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion or (c) in which we are requireddeemed to be recordeda large accelerated filer, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.

Further, even after we no longer qualify as an emerging growth company, we may still qualify as a component“smaller reporting company,” which would allow us to take advantage of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and at fair value in each balance sheet date thereafter. Changes in the estimated fair valuemany of the warrants are recognizedsame exemptions from disclosure requirements, including reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We cannot predict if investors will find our common shares less attractive because we may rely on these exemptions. If some investors find our common shares less attractive as a non-cash gain or loss on the statements of operations. Costs associated with issuing the warrants accountedresult, there may be a less active trading market for as liabilities are charged to operations when the warrants are issued. The fair value of the public warrantsour common shares and the private placement warrants were initially estimated using a Monte Carlo simulation approach. Following the separate trading of the Company’s common stock and public warrants, the private placement warrants fair values were estimated using a Black-Scholes-Merton approach.our share price may be more volatile.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKRISKS

Our operations are primarily within the United States and we transact only in United States dollars. Therefore, we do not have any material foreign currency exposure. We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates and foreign currency exchange rates.

Interest Risk

We were incorporated in Delaware on January 24, 2020 for the purpose of effecting an Initial Business Combination. Ashad cash, cash equivalents and restricted cash totaling $271.5 million as of March 31, 2022. Cash equivalents were invested primarily in money market funds. Our investment policy is focused on the preservation of capital and supporting our liquidity needs. Under the policy, we invest in highly rated securities, issued by the U.S. government or liquid money market funds. We do not invest in financial instruments for trading or speculative purposes, nor do we use leveraged financial instruments. We utilize external investment managers who adhere to the guidelines of

17

our investment policy. A hypothetical 10% change in interest rates would not have a material impact on the value of our cash, cash equivalents, net loss or cash flows.

We have exposure to interest rate risk from our variable rate debt. We do not hedge our exposure to changes in interest rates. At December 31, 2021, we had $9.9 million in variable rate debt outstanding. A hypothetical 10% change in interest rates would not commenced anyhave a material impact on annualized interest expense.

Inflation Risk

Our results of operations or generated any revenues. All activity through March 31, 2021 relatesand financial condition are presented based on historical cost. While it is difficult to our formation and our Public Offering and subsequentaccurately measure the impact of inflation due to the Public Offering identifying and completing a suitable Initial Business Combination. $172,500,000imprecise nature of the net proceedsestimates required, we believe the effects of the Public Offeringinflation, if any, on our results of operations and the Private Placement that closed in August 2020financial condition have been immaterial. Nonetheless, if our costs were deposited into a Trust Account that invests solely in U.S. government treasury bills with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940 which invest only in direct U. S. government obligations. In August 2020, the money market fund was largely liquidated and the trust assets were invested in U.S. government treasury bills which mature in February 2020 and currently yield approximately 0.1% on a yearly basis. At March 31, 2021, there was approximately $172,598,000to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs. We cannot assure you our business will not be affected in the Trust Account.future by inflation.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosuredisclosure controls and procedures are

We maintain disclosure controls and other procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controlsforms, and procedures include, without limitation, controls and procedures designed to ensure that such information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officerprincipal executive officer and Chief Financial Officer,principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.disclosures. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of our controls and procedures relative to their costs.

On April 12, 2021,Our management, with the SEC issued a Staff Statement on Accountingparticipation of our principal executive officer and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPAC’s”), the “Statement.” In the Statement, the SEC indicates its view that certain termsprincipal financial officer, evaluated, as of the warrants issued in connection with a SPAC Initial Public Offering (“Public Warrants”) and private placement warrants typically issuedend of the period covered by a SPAC (“Private Warrants”) call for such warrants to be accounted for as liabilities and not as equity. The Company has recorded such warrants as equity. This determination (liability vs. equity) has caused the Company to restate previously issued financial statements that showed the warrants as equity. Therefore, our management concluded that we did not maintain effective internal control over financial reporting as of March 31, 2021, December 31, 2020 and September 30, 2020, due to a material weakness in our internal control over financial reporting related to a lack of an effectively designed control over the evaluation of settlement features used to determine the classification of warrant instruments. The need to restate financial statements in this instance constitutes a material weakness in internal control.

In light of this material weakness at March 31, 2021, December 31, 2020 and September 30, 2020, we modified our procedures to include employing consultants on valuation and specialized knowledge on warrant accounting and we performed additional analysis as deemed necessary to ensure that our financial statements at March 31, 2021 were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q, present fairly in all material respects our financial position, results of operations and cash flows for the period presented.


As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2021. Based upon their evaluation, including the discussion in the previous paragraph, our Chief Executive Officer and Chief Financial Officer concluded(as that our disclosure controls and procedures (asterm is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of March 31, 2021.

Changes in Internal Control over Financial Reporting

During2022, due to the three months ended March 31, 2021, there has been no changematerial weaknesses in our internal control over financial reporting as described below.

Material Weaknesses in Internal Control over Financial Reporting

We have identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.

We did not design and maintain an effective control environment commensurate with our financial reporting requirements. Specifically, we lacked a sufficient complement of personnel with an appropriate level of internal controls and accounting knowledge, training and experience commensurate with our financial reporting requirements. Additionally, the limited personnel resulted in our inability to consistently establish appropriate authorities and responsibilities in pursuit of our financial reporting objectives, as demonstrated by, among other things, insufficient segregation of duties in our finance and accounting functions. This material weakness contributed to the following additional material weaknesses:

We did not design and maintain effective controls over the period-end financial reporting process to achieve complete, accurate and timely financial accounting, reporting and disclosures, including the classification of various accounts in the consolidated financial statements.

18

We did not design and maintain processes and controls to analyze, account for and disclose non-routine, unusual or complex transactions.  Specifically, we did not design and maintain controls to timely analyze and account for debt modifications and extinguishments, convertible notes, warrant instruments, non-routine complex revenue transactions including the leasing of products and transfer of inventory for leased assets into property plant and equipment, merger transactions, and the accounting and valuation of earn out liabilities.
We did not design and maintain formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures, including segregation of duties and controls over the preparation and review of account reconciliations and journal entries.
We did not design and maintain effective controls to ensure the recording of revenue transactions in the appropriate period.
We did not design and maintain effective controls over the completeness and accuracy of accounts payable and accrued liabilities.

These material weaknesses resulted in audit adjustments and certain immaterial misstatements in the Evolv financial statements to prepaid and other current assets, accounts payable and accrued liabilities, long-term and short-term debt, convertible notes, contingent earnout liabilities, change in fair value of contingent earn-out liability, equity, commission assets, contract asset, revenue, deferred revenue, accounts receivable, inventory, property plant and equipment, cost of sales and various expense line items and related financial statement disclosures as of and for the years ended December 31, 2019, 2020 and 2021. The material weakness related to accounting for warrant instruments resulted in the restatement of the previously issued financial statements of the entity acquired as part of the July 16, 2021 Merger Agreement related to warrant liabilities and equity. Additionally, these material weaknesses could result in a misstatement of substantially all of our accounts or disclosures that would result in a material misstatement to the annual or interim financial statements that would not be prevented or detected.

We did not design and maintain effective controls over information technology (“IT”) general controls for information systems that are relevant to the preparation of our consolidated financial statements, specifically, with respect to: (i) program change management controls for financial systems to ensure that IT program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate company personnel; (iii) computer operations controls to ensure that critical batch jobs are monitored and data backups are authorized and monitored, and (iv) testing and approval controls for program development to ensure that new software development is aligned with business and IT requirements. These IT deficiencies did not result in a misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.

Remediation Plan for the Material Weaknesses

We continue to be focused on designing and implementing effective internal controls to improve our internal control over financial reporting and remediate the material weaknesses. Our efforts include a number of actions:

We have hired, and are in the process of hiring additional accounting, internal audit and IT personnel, to bolster our reporting, technical accounting, internal control and IT capabilities. Additionally, we are in the process of designing and implementing controls to formalize roles and review responsibilities to align with

19

our team’s skills and experience and designing and implementing controls over segregation of duties and have engaged outside consultants to assist us in these efforts.
We added, and continue to add, finance personnel, including a Chief Financial Officer and Chief Accounting Officer and Corporate Controller, to the organization to strengthen our internal accounting team, to provide oversight, structure and reporting lines, and to provide additional review over our disclosures.
We are in the process of designing and implementing controls related to the period-end financial reporting process and controls over the classification of various accounts in our consolidated financial statements.
We are in the process of designing and implementing controls to timely identify and account for non-routine, unusual or complex transactions, including controls over the preparation and review of accounting memorandum addressing these matters.
We are in the process of designing and implementing controls related to revenue recognition, including non-routine complex revenue transactions that may also include the leasing of products and the recording of revenue transactions in the appropriate period.
We are in the process of designing and implementing controls over the completeness and accuracy of accounts payable and accrued liabilities.
We are in the process of designing and maintaining formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures, including controls over the preparation and review of account reconciliations and journal entries.
We are in the process of designing and implementing information technology general controls, including controls over program change management, the review and update of user access rights and privileges, controls over batch jobs and data backups, and program development approvals and testing. During the three months ended March 31, 2022, our outside consultants continued to assist us in the evaluation and implementation of a new ERP system.

The process of designing and maintaining effective internal control over financial reporting is a continuous effort that requires management to anticipate and react to changes in our business, economic and regulatory environments and to expend significant resources. As we continue to evaluate our internal control over financial reporting, we may take additional actions to remediate the material weaknesses or modify the remediation actions described above.

While we continue to devote significant time and attention to these remediation efforts, the material weaknesses will not be considered remediated until management completes the design and implementation of the actions described above and the controls operate for a sufficient period of time, and management has concluded, through testing, that these controls are effective.

Changes in Internal Control over Financial Reporting

Other than changes to our internal control over financial reporting described in “Material Weaknesses in Internal Control over Financial Reporting” and “Remediation Plan for the Material Weakness” above, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2022 that have materially affected, or isare reasonably likely to materially affect, our internal control over financial reporting except as described below.

In light of the restatement of the previously filed financial statements, we are enhancing our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements. Our plans at this time include retaining consultants with technical accounting expertise in derivatives accounting as well as valuation consultants with expertise in warrants and other derivative instruments. We believe our efforts will enhance our controls relating to warrant accounting, but we can offer no assurance that our controls will not require additional review and modification in the future as industry accounting practices based on the SEC Statement may evolve over time.

22reporting.

20

PART II OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are from time to time subject to various claims, lawsuits, and other legal and administrative proceedings arising in the ordinary course of business. We are not currently engaged in any litigation or criminal proceedings. See Note 20 (Commitments and Contingencies) to our condensed consolidated financial statements in Item 1. Part I of this Report.

None.

ITEM 1A. RISK FACTORS

As of the date of this Quarterly Report on Form 10-Q, thereThere have been no material changes to the risk factors discloseddescribed in our ProspectusAnnual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on JulyMarch 28, 2020 or2022. For a discussion of potential risks and uncertainties related to us, see Part I, Item 1A, "Risk Factors" of our Annual Report as amended on Form 10-K/A filed on May 14,10-K for the year ended December 31, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Unregistered Sales of Equity Securities

None

During the three months ended March 31, 2022, we did not sell any securities that were not registered under the Securities Act.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.


21

ITEM 6.EXHIBITS

Incorporated by Reference

Exhibit
No.

    

Description

    

Form

    

File Number

    

Exhibit

    

Filing Date

    

Filed/Furnished
Herewith

3.1

Second Amended and Restated Certificate of Incorporation.

Form 10-Q

001-39417

3.1

November 15, 2021

3.2

Amended and Restated Bylaws.

Form 8-K

001-39417

3.2

July 22, 2021

31.1

Certification of Principal Executive Officer pursuant to Exchange Act Rule 13a-14(a).

*

31.2

Certification of Principal Financial Officer pursuant to Exchange Act Rule 13a-14(a).

*

32.1

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350.

**

32.2

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350.

**

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

*

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

*

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

*

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

*

101.LAB

Inline XBRL Taxonomy Extension Labels Linkbase Document.

*

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

*

104

Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

*

* Filed herewith.

Exhibit Number**

Description
31.1

Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.Furnished herewith.

31.2

Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.

32.1*

Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.

32.2*Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
101.INSXBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

22

*Furnished herewith

SIGNATURES

In accordance withPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.authorized.

NEWHOLD INVESTMENT CORP.

EVOLV TECHNOLOGIES HOLDINGS, INC.

Dated:

Date: May 24, 2021   13, 2022

By:

/s/ Kevin CharltonMario Ramos

Name: 

Kevin Charlton

Mario Ramos

Title:Chairman of the Board of Directors and
Chief Executive Officer
(Principal Executive Officer)  

 

Dated: May 24, 2021   /s/ Adam Deutsch

Name: 

Adam Deutsch
Title:Executive Vice President,

Chief

Financial Officer and Secretary
(Principal Financial and Accounting Officer)  Chief Risk Officer (principal financial officer)

25

23